Overexpression	O
of	O
p65	O
and	O
c-Jun	O
substitutes	O
for	O
B7-1	O
costimulation	O
by	O
targeting	O
the	O
CD28RE	B-DNA
within	O
the	O
IL-2	B-DNA
promoter	I-DNA
.	O

The	O
role	O
of	O
Rel	B-protein
and	O
activation	B-protein
protein-1	I-protein
(	O
AP-1	B-protein
)	O
in	O
IL-2	B-DNA
promoter	I-DNA
activity	O
in	O
B7-1-	B-cell_type
and	I-cell_type
leukocyte	I-cell_type
function-associated	I-cell_type
Ag-3	I-cell_type
(	I-cell_type
LFA.	I-cell_type
3	I-cell_type
)	I-cell_type
-costimulated	I-cell_type
T	I-cell_type
cells	I-cell_type
has	O
been	O
evaluated	O
.	O

We	O
demonstrate	O
that	O
overexpression	O
of	O
c-Jun	B-protein
but	O
not	O
c-Fos	B-protein
increases	O
IL-2	B-DNA
promoter	I-DNA
activity	O
in	O
both	O
B7-1-	B-cell_type
and	I-cell_type
LFA-3-costimulated	I-cell_type
Jurkat	I-cell_type
T	I-cell_type
cells	I-cell_type
.	O

Cotransfection	O
of	O
both	O
c-Jun	O
and	O
c-Fos	O
substitutes	O
for	O
B7-1	O
costimulation	O
in	O
driving	O
an	O
activation	B-DNA
protein-1	I-DNA
response	I-DNA
element	I-DNA
but	O
not	O
for	O
the	O
IL-2	B-DNA
promoter	I-DNA
.	O

Overexpression	O
of	O
Rel	B-protein
proteins	I-protein
demonstrated	O
that	O
p65-expressing	B-cell_line
Jurkat	I-cell_line
cells	I-cell_line
transcribed	O
equally	O
well	O
a	O
nuclear	B-DNA
factor	I-DNA
kappabeta	I-DNA
reporter	I-DNA
construct	I-DNA
when	O
costimulated	O
with	O
B7-1	B-protein
or	O
LFA-3	B-protein
,	O
but	O
transcription	O
of	O
IL-2	B-DNA
promoter	I-DNA
or	O
CD28	B-DNA
response	I-DNA
element	I-DNA
(	I-DNA
CD28RE	I-DNA
)	I-DNA
-driven	I-DNA
reporters	I-DNA
was	O
superior	O
in	O
B7-1-costimulated	B-cell_line
cells	I-cell_line
.	O

Combined	O
expression	O
of	O
c-Jun	B-protein
and	O
p65	B-protein
induced	O
vigorous	O
transcription	O
of	O
IL-2	B-DNA
promoter-	I-DNA
and	I-DNA
CD28RE-driven	I-DNA
reporter	I-DNA
constructs	I-DNA
in	O
both	O
LFA-3-	B-cell_type
and	I-cell_type
B7-1-costimulated	I-cell_type
Jurkat	I-cell_type
cells	I-cell_type
.	O

Mutating	O
the	O
CD28RE	B-DNA
but	O
not	O
the	O
upstream	B-DNA
nuclear	I-DNA
factor	I-DNA
kappabeta-binding	I-DNA
site	I-DNA
in	O
the	O
IL-2	B-DNA
promoter	I-DNA
reduced	O
B7-1	B-protein
-driven	O
transcription	O
>	O
90	O
%	O
.	O

The	O
results	O
implicates	O
a	O
major	O
role	O
of	O
the	O
CD28RE	B-DNA
in	O
the	O
integration	O
of	O
p65	B-protein
/	O
c-Jun	B-protein
-mediated	O
transcription	O
within	O
the	O
IL-2	B-DNA
promoter	I-DNA
.	O

We	O
suggest	O
that	O
the	O
transition	O
from	O
an	O
autocrine	O
LFA-3	B-protein
-driven	O
immune	O
response	O
to	O
a	O
B7	O
--	O
induced	O
paracrine	O
immune	O
response	O
involves	O
the	O
activation	O
of	O
c-Jun	B-protein
and	O
p65	B-protein
,	O
which	O
target	O
the	O
CD28RE	B-DNA
region	O
of	O
the	O
IL-2	B-DNA
promoter	I-DNA
.	O

£9	NULL
Analytes	NULL
=	NULL
Comprehensive	NULL
Analysis	NULL
(	NULL
s	NULL
Microwuée	NULL
Ar	NULL
aect	NULL
s	NULL
at	NULL
SCS5b-9	NULL
,	NULL
Factor	NULL
H	NULL
,	NULL
Factor	NULL
|	NULL
QUIDEL	NULL
MULTIPLE	NULL
<	NULL
‘	NULL
For	NULL
Research	NULL
Use	NULL
Only	NULL
menos	NULL
popper	NULL
*	NULL
#	NULL
s	NULL
meJournal	NULL
o	NULL
Overexpression	NULL
of	NULL
p65	NULL
and	NULL
c-Jun	NULL
Substitutes	NULL
for	NULL
ﬁé	NULL
‘	NULL
flmmunolo	NULL
gy	NULL
B7-1	NULL
Costimulation	NULL
by	NULL
Targeting	NULL
the	NULL
CD28RE	NULL
Within	NULL
the	NULL
IL-2	NULL
Promoter	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
Eduardo	NULL
Parra	NULL
,	NULL
Kathleen	NULL
McGuire	NULL
,	NULL
Gunnar	NULL
Hedlund	NULL
and	NULL
Mikael	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Dohlsten	NULL
J	NULL
Immunol	NULL
1998	NULL
;	NULL
160:5374-5381	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/160/11/5374	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
59	NULL
articles	NULL
,	NULL
26	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/160/1	NULL
1/5374	NULL
.	NULL

full	NULL
#	NULL
ref-list-	NULL
1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
Overexpression	NULL
of	NULL
p65	NULL
and	NULL
c-Jun	NULL
Substitutes	NULL
for	NULL
B7-1	NULL
Costimulation	NULL
by	NULL
Targeting	NULL
the	NULL
CD28RE	NULL
Within	NULL
the	NULL
IL-2	NULL
Promoter	NULL
'	NULL
Eduardo	NULL
Parra	NULL
,	NULL
*	NULL
Kathleen	NULL
McGuire	NULL
,	NULL
``	NULL
Gunnar	NULL
Hedlund	NULL
,	NULL
*	NULL
``	NULL
and	NULL
Mikael	NULL
Dohlsten	NULL
``	NULL
**	NULL
The	NULL
role	NULL
of	NULL
Rel	NULL
and	NULL
activation	NULL
protein-1	NULL
(	NULL
AP-1	NULL
)	NULL
in	NULL
IL-2	NULL
promoter	NULL
activity	NULL
in	NULL
B7-1-	NULL
and	NULL
leukocyte	NULL
function-associated	NULL
Ag-3	NULL
(	NULL
LFA-3	NULL
)	NULL
-costimulated	NULL
T	NULL
cells	NULL
has	NULL
been	NULL
evaluated	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
overexpression	NULL
of	NULL
c-Jun	NULL
but	NULL
not	NULL
c-Fos	NULL
increases	NULL
IL-2	NULL
promoter	NULL
activity	NULL
in	NULL
both	NULL
B7-1-	NULL
and	NULL
LFA-3-costimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Cotransfection	NULL
of	NULL
both	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
substitutes	NULL
for	NULL
B7-1	NULL
costimulation	NULL
in	NULL
driving	NULL
an	NULL
activation	NULL
protein-1	NULL
response	NULL
element	NULL
but	NULL
not	NULL
for	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

Overexpression	NULL
of	NULL
Rel	NULL
proteins	NULL
demonstrated	NULL
that	NULL
p6S-expressing	NULL
Jurkat	NULL
cells	NULL
transcribed	NULL
equally	NULL
well	NULL
a	NULL
nuclear	NULL
factor	NULL
xB	NULL
reporter	NULL
construct	NULL
when	NULL
costimulated	NULL
with	NULL
B7-1	NULL
or	NULL
LFA-3	NULL
,	NULL
but	NULL
transcription	NULL
of	NULL
IL-2	NULL
promoter	NULL
or	NULL
CD28	NULL
response	NULL
element	NULL
(	NULL
CD28RE	NULL
)	NULL
-driven	NULL
reporters	NULL
was	NULL
superior	NULL
in	NULL
B7-1-costimulated	NULL
cells	NULL
.	NULL

Combined	NULL
expression	NULL
of	NULL
c-Jun	NULL
and	NULL
p65	NULL
induced	NULL
vigorous	NULL
transcription	NULL
of	NULL
IL-2	NULL
promoter-	NULL
and	NULL
CD28RE-driven	NULL
reporter	NULL
constructs	NULL
in	NULL
both	NULL
LFA-3-	NULL
and	NULL
B7-1-costimulated	NULL
Jurkat	NULL
cells	NULL
.	NULL

Mutating	NULL
the	NULL
CD28RE	NULL
but	NULL
not	NULL
the	NULL
upstream	NULL
nuclear	NULL
factor	NULL
«	NULL
f3-binding	NULL
site	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
reduced	NULL
B7-1-driven	NULL
transcription	NULL
>	NULL
90	NULL
%	NULL
.	NULL

The	NULL
results	NULL
implicates	NULL
a	NULL
major	NULL
role	NULL
of	NULL
the	NULL
CD28RE	NULL
in	NULL
the	NULL
integration	NULL
of	NULL
p65/c-Jun-mediated	NULL
transcription	NULL
within	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

We	NULL
suggest	NULL
that	NULL
the	NULL
transition	NULL
from	NULL
an	NULL
autocrine	NULL
LFA-3-driven	NULL
immune	NULL
response	NULL
to	NULL
a	NULL
B7	NULL
--	NULL
induced	NULL
paracrine	NULL
immune	NULL
response	NULL
involves	NULL
the	NULL
activation	NULL
of	NULL
c-Jun	NULL
and	NULL
p65	NULL
,	NULL
which	NULL
target	NULL
the	NULL
CD28RE	NULL
region	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

cient	NULL
for	NULL
activation	NULL
of	NULL
cytokine	NULL
production	NULL
and	NULL
cell	NULL
prolif-	NULL
eration	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

Second	NULL
signals	NULL
provided	NULL
by	NULL
the	NULL
APC	NULL
are	NULL
required	NULL
to	NULL
promote	NULL
complete	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

These	NULL
signals	NULL
result	NULL
from	NULL
the	NULL
interaction	NULL
of	NULL
cell	NULL
surface	NULL
protein	NULL
ligands	NULL
such	NULL
as	NULL
B7-1	NULL
(	NULL
CD80	NULL
)	NULL
,	NULL
B7-2	NULL
CD86	NULL
)	NULL
,	NULL
or	NULL
LFEA-3	NULL
(	NULL
CD58	NULL
)	NULL
on	NULL
the	NULL
APCs	NULL
with	NULL
the	NULL
corresponding	NULL
CD28	NULL
or	NULL
CD2	NULL
receptors	NULL
on	NULL
T	NULL
cells	NULL
(	NULL
4-12	NULL
)	NULL
.	NULL

The	NULL
complete	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
leads	NULL
to	NULL
induction	NULL
of	NULL
IL-2	NULL
and	NULL
IL-2R	NULL
gene	NULL
expression	NULL
and	NULL
subsequent	NULL
cell	NULL
division	NULL
.	NULL

IL-2	NULL
gene	NULL
expression	NULL
is	NULL
regulated	NULL
by	NULL
its	NULL
5'-promoter	NULL
sequence	NULL
,	NULL
and	NULL
its	NULL
critical	NULL
regulatory	NULL
and	NULL
inducible	NULL
activity	NULL
is	NULL
contained	NULL
within	NULL
the	NULL
300-bp	NULL
region	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
start	NULL
site	NULL
.	NULL

The	NULL
IL-2	NULL
promoter	NULL
includes	NULL
defined	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
transcription	NULL
factors	NULL
NF-AT	NULL
,	NULL
``	NULL
NF-KB	NULL
,	NULL
AP-1	NULL
,	NULL
Oct-1	NULL
,	NULL
and	NULL
CD28RC	NULL
(	NULL
13-16	NULL
)	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

family	NULL
of	NULL
transcription	NULL
factors	NULL
has	NULL
been	NULL
shown	NULL
by	NULL
several	NULL
laboratories	NULL
to	NULL
be	NULL
important	NULL
to	NULL
IL-2	NULL
promoter	NULL
activity	NULL
.	NULL

These	NULL
transcription	NULL
factors	NULL
share	NULL
the	NULL
conserved	NULL
Rel	NULL
homology	NULL
do-main	NULL
,	NULL
involved	NULL
in	NULL
specific	NULL
DNA	NULL
binding	NULL
and	NULL
dimerization	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Rel	NULL
proteins	NULL
interact	NULL
with	NULL
the	NULL
regulatory	NULL
elements	NULL
of	NULL
many	NULL
different	NULL
inducible	NULL
immune	NULL
response	NULL
genes	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

family	NULL
of	NULL
transcription	NULL
factors	NULL
includes	NULL
p50	NULL
p52	NULL
(	NULL
NFxB2	NULL
)	NULL
,	NULL
p65	NULL
(	NULL
Rel	NULL
A	NULL
)	NULL
,	NULL
Rel	NULL
B	NULL
,	NULL
and	NULL
c-Rel	NULL
(	NULL
18-20	NULL
)	NULL
.	NULL

p65	NULL
and	NULL
c-Rel	NULL
contain	NULL
different	NULL
and	NULL
unique	NULL
C-terminal	NULL
transcription	NULL
activation	NULL
domains	NULL
(	NULL
21-23	NULL
)	NULL
.	NULL

Several	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
both	NULL
the	NULL
p65	NULL
(	NULL
22	NULL
)	NULL
and	NULL
c-Rel	NULL
S	NULL
timulation	NULL
of	NULL
T	NULL
cells	NULL
through	NULL
the	NULL
TCR	NULL
alone	NULL
is	NULL
not	NULL
suffi-	NULL
*The	NULL
Wallenberg	NULL
Laboratory	NULL
,	NULL
Section	NULL
for	NULL
Tumour	NULL
Immunology	NULL
,	NULL
Department	NULL
of	NULL
Cell	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
Lund	NULL
,	NULL
and	NULL
*Pharmacia	NULL
&	NULL
Upjohn	NULL
,	NULL
Lund	NULL
,	NULL
Swe-den	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Biology	NULL
and	NULL
Molecular	NULL
Biology	NULL
Institute	NULL
,	NULL
San	NULL
Diego	NULL
State	NULL
University	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
92182	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Swedish	NULL
Cancer	NULL
Society	NULL
and	NULL
The	NULL
LEO	NULL
Research	NULL
Foundation	NULL
.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Mikael	NULL
Dohlsten	NULL
,	NULL
Astra	NULL
Draco	NULL
AB	NULL
,	NULL
Preclinical	NULL
R	NULL
&	NULL
D	NULL
,	NULL
Box	NULL
34	NULL
,	NULL
S-221	NULL
00	NULL
Lund	NULL
,	NULL
Sweden	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
mikael.dohlsten	NULL
@	NULL
draco.se.astra.com	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
NF-AT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
lymphocytes	NULL
;	NULL
CHO	NULL
,	NULL
Chinese	NULL
hamster	NULL
ovary	NULL
;	NULL
SEE	NULL
,	NULL
staphylococcal	NULL
enterotoxin	NULL
E	NULL
;	NULL
AP-1	NULL
,	NULL
activation	NULL
protein-1	NULL
;	NULL
CD28RE	NULL
,	NULL
CD28	NULL
response	NULL
element	NULL
;	NULL
JNK	NULL
,	NULL
Jun	NULL
N-terminal	NULL
kinase	NULL
;	NULL
RLU	NULL
,	NULL
arbitrary	NULL
light	NULL
units	NULL
.	NULL

Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1998	NULL
,	NULL
160	NULL
;	NULL
5374-5381	NULL
.	NULL

(	NULL
24	NULL
)	NULL
proteins	NULL
contain	NULL
a	NULL
potent	NULL
franms-activating	NULL
capacity	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
p50	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
subunit	NULL
shows	NULL
a	NULL
substantial	NULL
DNA-binding	NULL
capacity	NULL
and	NULL
low	NULL
transcriptional	NULL
activity	NULL
,	NULL
suggesting	NULL
a	NULL
role	NULL
for	NULL
p50	NULL
homodimers	NULL
in	NULL
repressing	NULL
p65-	NULL
and	NULL
c-Rel-responsive	NULL
genes	NULL
.	NULL

The	NULL
NF-KB	NULL
proteins	NULL
are	NULL
retained	NULL
in	NULL
the	NULL
cytoplasm	NULL
in	NULL
an	NULL
inactive	NULL
state	NULL
by	NULL
complex	NULL
formation	NULL
with	NULL
the	NULL
IxB-inhibitory	NULL
subunits	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Cell	NULL
activation	NULL
induces	NULL
the	NULL
phosphorylation	NULL
of	NULL
IxB-a	NULL
and	NULL
its	NULL
subsequent	NULL
proteolytic	NULL
degradation	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
is	NULL
dissociated	NULL
from	NULL
the	NULL
negative	NULL
regulator	NULL
IB	NULL
,	NULL
is	NULL
translocated	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
and	NULL
binds	NULL
to	NULL
the	NULL
xB	NULL
decameric	NULL
sequence	NULL
motif	NULL
(	NULL
25	NULL
,	NULL
27-29	NULL
)	NULL
.	NULL

The	NULL
CD28RE	NULL
within	NULL
the	NULL
IL-2	NULL
promoter	NULL
contains	NULL
a	NULL
sequence	NULL
similar	NULL
to	NULL
but	NULL
not	NULL
identical	NULL
with	NULL
the	NULL
B	NULL
site	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Several	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

family	NULL
proteins	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
nuclear	NULL
protein	NULL
complex	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
CD28RE	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
response	NULL
element	NULL
is	NULL
a	NULL
modified	NULL
«	NULL
B	NULL
response	NULL
motif	NULL
(	NULL
31-33	NULL
)	NULL
.	NULL

CD28RE	NULL
was	NULL
originally	NULL
defined	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
as	NULL
a	NULL
major	NULL
and	NULL
unique	NULL
response	NULL
element	NULL
for	NULL
the	NULL
CD28/B7-1	NULL
signal	NULL
transduction	NULL
pathway	NULL
(	NULL
31	NULL
)	NULL
.	NULL

However	NULL
,	NULL
recent	NULL
data	NULL
suggest	NULL
that	NULL
induction	NULL
of	NULL
nuclear	NULL
proteins	NULL
binding	NULL
to	NULL
CD28RE	NULL
is	NULL
not	NULL
entirely	NULL
exclusive	NULL
for	NULL
the	NULL
CD28	NULL
pathway	NULL
(	NULL
16	NULL
,	NULL
34	NULL
,	NULL
35	NULL
)	NULL
and	NULL
similar	NULL
sequences	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
other	NULL
promoters	NULL
like	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
(	NULL
30	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
reported	NULL
that	NULL
B7-1	NULL
costimulation	NULL
induced	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
c-Rel-containing	NULL
CD28RC	NULL
complex	NULL
(	NULL
16	NULL
)	NULL
and	NULL
this	NULL
has	NULL
been	NULL
seen	NULL
by	NULL
other	NULL
laboratories	NULL
as	NULL
well	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
AP-1	NULL
transcription	NULL
factors	NULL
are	NULL
composed	NULL
of	NULL
Jun	NULL
and	NULL
Fos	NULL
proteins	NULL
that	NULL
function	NULL
as	NULL
transcriptional	NULL
regulators	NULL
in	NULL
a	NULL
het-erodimeric	NULL
complex	NULL
(	NULL
37-39	NULL
)	NULL
.	NULL

The	NULL
members	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
family	NULL
together	NULL
with	NULL
ATF	NULL
,	NULL
CREB	NULL
,	NULL
and	NULL
others	NULL
belong	NULL
to	NULL
the	NULL
class	NULL
of	NULL
basic-leucine	NULL
zipper	NULL
(	NULL
bZIP	NULL
)	NULL
proteins	NULL
.	NULL

Following	NULL
cell	NULL
acti-vation	NULL
,	NULL
members	NULL
of	NULL
the	NULL
Jun	NULL
family	NULL
(	NULL
c-Jun	NULL
,	NULL
Jun	NULL
D	NULL
,	NULL
and	NULL
Jun	NULL
B	NULL
)	NULL
form	NULL
complexes	NULL
with	NULL
various	NULL
partners	NULL
of	NULL
the	NULL
Fos	NULL
family	NULL
(	NULL
c-Fos	NULL
,	NULL
Fos	NULL
B	NULL
,	NULL
Fra-1	NULL
,	NULL
and	NULL
Fra-2	NULL
)	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
heterodimers	NULL
seems	NULL
to	NULL
increase	NULL
their	NULL
transcriptional	NULL
activity	NULL
(	NULL
40	NULL
)	NULL
.	NULL

The	NULL
c-Jun	NULL
but	NULL
not	NULL
the	NULL
c-Fos	NULL
protein	NULL
may	NULL
also	NULL
form	NULL
homodimers	NULL
.	NULL

However	NULL
,	NULL
the	NULL
heterodimers	NULL
formed	NULL
by	NULL
one	NULL
member	NULL
of	NULL
each	NULL
family	NULL
display	NULL
higher	NULL
DNA-binding	NULL
capacity	NULL
and	NULL
frams-activating	NULL
properties	NULL
than	NULL
homodimers	NULL
0022-1767/98/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
formed	NULL
by	NULL
the	NULL
Jun	NULL
family	NULL
members	NULL
.	NULL

The	NULL
consensus	NULL
AP-1-binding	NULL
site	NULL
has	NULL
been	NULL
identified	NULL
in	NULL
several	NULL
genes	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
(	NULL
37-39	NULL
)	NULL
.	NULL

The	NULL
AP-1	NULL
proteins	NULL
have	NULL
been	NULL
demonstrated	NULL
to	NULL
complex	NULL
with	NULL
NF-AT	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
Oct-1	NULL
proteins	NULL
,	NULL
suggesting	NULL
that	NULL
AP-1	NULL
may	NULL
act	NULL
in	NULL
concert	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
to	NULL
regulate	NULL
a	NULL
variety	NULL
of	NULL
response	NULL
elements	NULL
(	NULL
41-46	NULL
)	NULL
.	NULL

To	NULL
elucidate	NULL
the	NULL
role	NULL
of	NULL
Rel	NULL
and	NULL
AP-1	NULL
proteins	NULL
in	NULL
costimulation	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
used	NULL
a	NULL
model	NULL
with	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
CHO	NULL
cells	NULL
transfected	NULL
with	NULL
HLA-DR	NULL
,	NULL
B7-1	NULL
,	NULL
and	NULL
LFA-3	NULL
as	NULL
APCs	NULL
.	NULL

Transient	NULL
transfection	NULL
of	NULL
Jurkat	NULL
cells	NULL
with	NULL
IL-2	NULL
promoter	NULL
AP-1	NULL
,	NULL
NF-kB	NULL
and	NULL
CD28RE-driven	NULL
reporter	NULL
combined	NULL
with	NULL
Rel	NULL
and	NULL
AP-1	NULL
expression	NULL
plasmids	NULL
was	NULL
performed	NULL
to	NULL
study	NULL
the	NULL
role	NULL
of	NULL
these	NULL
proteins	NULL
in	NULL
IL-2	NULL
promoter	NULL
transcription	NULL
.	NULL

We	NULL
now	NULL
demonstrate	NULL
that	NULL
c-Jun	NULL
functionally	NULL
cooperates	NULL
with	NULL
p65	NULL
in	NULL
superinducing	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

Indeed	NULL
,	NULL
c-Jun/p65-expressing	NULL
Jurkat	NULL
cells	NULL
responded	NULL
equally	NULL
well	NULL
to	NULL
B7-1	NULL
and	NULL
LFA-3	NULL
costimulation	NULL
.	NULL

The	NULL
CD28RE	NULL
seemed	NULL
to	NULL
be	NULL
crucial	NULL
for	NULL
p65/c-Jun	NULL
effects	NULL
,	NULL
since	NULL
a	NULL
mutation	NULL
in	NULL
this	NULL
site	NULL
completely	NULL
abrogated	NULL
the	NULL
superinduction	NULL
of	NULL
IL-2	NULL
promoter	NULL
activity	NULL
.	NULL

The	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
CD28RE	NULL
,	NULL
flanked	NULL
by	NULL
an	NULL
AP-1	NULL
element	NULL
,	NULL
integrates	NULL
AP-1	NULL
and	NULL
Rel	NULL
nuclear	NULL
factor	NULL
pathways	NULL
to	NULL
transfer	NULL
T	NULL
cells	NULL
from	NULL
an	NULL
autocrine	NULL
to	NULL
a	NULL
paracrine	NULL
immune	NULL
response	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Reagents	NULL
SEE	NULL
was	NULL
purchased	NULL
from	NULL
Toxin	NULL
Technology	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Luciferase	NULL
assay	NULL
reagent	NULL
,	NULL
reporter	NULL
lysis	NULL
buffer	NULL
5X	NULL
,	NULL
and	NULL
the	NULL
pGL2	NULL
luciferase	NULL
basic	NULL
vector	NULL
were	NULL
purchase	NULL
from	NULL
Promega	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

rIL-2	NULL
was	NULL
obtained	NULL
from	NULL
Cetus	NULL
(	NULL
Emeryville	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Transfected	NULL
cell	NULL
lines	NULL
CHO	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
cDNAs	NULL
encoding	NULL
the	NULL
human	NULL
HLA-DR4	NULL
,	NULL
B7-1	NULL
,	NULL
and	NULL
LFA-3	NULL
cell	NULL
surface	NULL
molecules	NULL
,	NULL
as	NULL
described	NULL
in	NULL
detail	NULL
elsewhere	NULL
(	NULL
12	NULL
,	NULL
47	NULL
)	NULL
.	NULL

Single	NULL
,	NULL
double	NULL
,	NULL
and	NULL
triple	NULL
transfectants	NULL
expressing	NULL
similar	NULL
levels	NULL
of	NULL
the	NULL
transfected	NULL
molecules	NULL
were	NULL
established	NULL
by	NULL
repeated	NULL
cell	NULL
sortings	NULL
.	NULL

The	NULL
surface	NULL
expression	NULL
of	NULL
HLA-DR	NULL
,	NULL
LFA-3	NULL
,	NULL
and	NULL
B7-1	NULL
was	NULL
confirmed	NULL
regularly	NULL
by	NULL
FACS	NULL
analysis	NULL
.	NULL

Cell	NULL
culture	NULL
and	NULL
transfection	NULL
All	NULL
experiments	NULL
were	NULL
done	NULL
using	NULL
the	NULL
human	NULL
T-cell	NULL
Jurkat	NULL
,	NULL
which	NULL
responds	NULL
with	NULL
a	NULL
pattern	NULL
of	NULL
IL-2	NULL
production	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
B7-1	NULL
and	NULL
LFA-3	NULL
costimulation	NULL
as	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
human	NULL
Jurkat	NULL
leukemia	NULL
T	NULL
cell	NULL
line	NULL
was	NULL
maintained	NULL
in	NULL
culture	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
2	NULL
mM	NULL
glutamine	NULL
and	NULL
10	NULL
%	NULL
FBS	NULL
(	NULL
complete	NULL
medium	NULL
)	NULL
.	NULL

All	NULL
tests	NULL
on	NULL
the	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
performed	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
X	NULL
10°	NULL
cells/ml	NULL
in	NULL
complete	NULL
me-dium	NULL
.	NULL

The	NULL
transfected	NULL
CHO	NULL
cells	NULL
were	NULL
irradiated	NULL
(	NULL
8000	NULL
rad	NULL
)	NULL
and	NULL
added	NULL
to	NULL
the	NULL
Jurkat	NULL
cells	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
0.1	NULL
X	NULL
10°	NULL
cells/ml	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Plasmid	NULL
construction	NULL
The	NULL
human	NULL
IL-2	NULL
promotor-enhancer	NULL
fragment	NULL
(	NULL
-500	NULL
to	NULL
+60	NULL
)	NULL
was	NULL
sub-cloned	NULL
from	NULL
plasmid	NULL
SV-IL-2-CAT	NULL
into	NULL
the	NULL
luciferase	NULL
vector	NULL
pGL2	NULL
(	NULL
Promega	NULL
)	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
AP-1-luciferase	NULL
reporter	NULL
plasmid	NULL
driven	NULL
by	NULL
the	NULL
rat	NULL
prolactin	NULL
minimal	NULL
promoter	NULL
(	NULL
-36	NULL
to	NULL
+37	NULL
)	NULL
under	NULL
the	NULL
control	NULL
of	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
human	NULL
AP-1	NULL
site	NULL
(	NULL
49	NULL
)	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
M.	NULL
Rincon	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
(	NULL
Section	NULL
of	NULL
Immunobiology	NULL
,	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Yale	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
)	NULL
.	NULL

The	NULL
IL-2	NULL
promotor	NULL
mutated	NULL
in	NULL
the	NULL
CD28RE	NULL
region	NULL
was	NULL
generated	NULL
by	NULL
PCR-directed	NULL
splicing	NULL
overlap	NULL
extension	NULL
.	NULL

The	NULL
PCR	NULL
replaced	NULL
6	NULL
bp	NULL
within	NULL
the	NULL
CD28RE	NULL
(	NULL
from	NULL
-159	NULL
to	NULL
-164	NULL
)	NULL
in	NULL
the	NULL
IL-2	NULL
enhancer	NULL
of	NULL
the	NULL
pGL-2-IL-2-Luc	NULL
vector	NULL
with	NULL
the	NULL
sequence	NULL
5	NULL
``	NULL
-CCTCGA-3	NULL
'	NULL
.	NULL

Plasmids	NULL
containing	NULL
multimers	NULL
of	NULL
the	NULL
recognition	NULL
sites	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
CD28RC	NULL
were	NULL
constructed	NULL
and	NULL
linked	NULL
to	NULL
the	NULL
pLuc-prolactin	NULL
minimal	NULL
promoter	NULL
plasmid	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
orientation	NULL
for	NULL
each	NULL
element	NULL
was	NULL
confirmed	NULL
by	NULL
restriction	NULL
enzyme	NULL
cleavage	NULL
.	NULL

The	NULL
tandem	NULL
sequences	NULL
used	NULL
to	NULL
construct	NULL
the	NULL
different	NULL
multimers	NULL
plasmids	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
1	NULL
)	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
CD28RE	NULL
(	NULL
CD28RE	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
5'-AAAGAAATTCC-3	NULL
'	NULL
;	NULL
2	NULL
)	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
AP-1	NULL
,	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
,	NULL
-	NULL
5'-TCGATTGAGTCAGGGTAA	NULL
3	NULL
'	NULL
;	NULL
3	NULL
)	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-binding	NULL
site	NULL
of	NULL
the	NULL
human	NULL
Ig	NULL
«	NULL
light	NULL
chain	NULL
enhancer	NULL
5	NULL
)	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
CD28RE/AP-1	NULL
sequence	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
-161	NULL
to	NULL
-138	NULL
)	NULL
was	NULL
cloned	NULL
in	NULL
three	NULL
copies	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
promoter	NULL
from	NULL
the	NULL
CR	NULL
version	NULL
of	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
leukemia/lymphoma	NULL
virus-1	NULL
long	NULL
terminal	NULL
repeat	NULL
,	NULL
3X	NULL
CAGAAATTC	NULL
5375	NULL
CAAAGAG	NULL
TCATCAGA	NULL
(	NULL
50	NULL
)	NULL
;	NULL
6	NULL
)	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
CD28RE/AP-1	NULL
construct	NULL
bearing	NULL
the	NULL
mutation	NULL
for	NULL
the	NULL
CD28RE	NULL
(	NULL
CD28REm	NULL
)	NULL
,	NULL
TTTAAAGC	NULL
CATTCCAAA	NULL
(	NULL
50	NULL
)	NULL
;	NULL
7	NULL
)	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
CD28RE/AP-1	NULL
construct	NULL
bearing	NULL
the	NULL
mutation	NULL
for	NULL
the	NULL
AP-1	NULL
(	NULL
AP-1	NULL
REm	NULL
)	NULL
,	NULL
CCAAAGAGAGATCA-GAA	NULL
(	NULL
50	NULL
)	NULL
;	NULL
8	NULL
)	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
CD28RE/AP-1	NULL
construct	NULL
bearing	NULL
a	NULL
double	NULL
mutation	NULL
for	NULL
the	NULL
CD28RE	NULL
(	NULL
CD28REm	NULL
)	NULL
and	NULL
AP-1	NULL
(	NULL
AP-1	NULL
m	NULL
)	NULL
,	NULL
3X	NULL
CA	NULL
GAAATTCCAAAGAGAGA	NULL
TCAGA	NULL
(	NULL
50	NULL
)	NULL
;	NULL
9	NULL
)	NULL
IL-2	NULL
promoter	NULL
construct	NULL
bearing	NULL
a	NULL
mutation	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
,	NULL
AAAGAGGCTTTTCACCT	NULL
(	NULL
50	NULL
)	NULL
.	NULL

DNA	NULL
transfection	NULL
and	NULL
luciferase	NULL
activity	NULL
analysis	NULL
Transfection	NULL
of	NULL
Jurkat	NULL
cells	NULL
was	NULL
conducted	NULL
by	NULL
electroporation	NULL
,	NULL
using	NULL
an	NULL
electro	NULL
cell	NULL
manipulator	NULL
600	NULL
(	NULL
BTX	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
using	NULL
130	NULL
V/1700	NULL
uF	NULL
capacitance	NULL
.	NULL

Briefly	NULL
,	NULL
8	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
pug	NULL
of	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
and	NULL
5	NULL
pg	NULL
of	NULL
each	NULL
expression	NULL
plasmid	NULL
,	NULL
and	NULL
the	NULL
mixture	NULL
was	NULL
incubated	NULL
for	NULL
24	NULL
h.	NULL
Cells	NULL
were	NULL
stimulated	NULL
with	NULL
the	NULL
different	NULL
CHO-transfected	NULL
cell	NULL
lines	NULL
with	NULL
or	NULL
without	NULL
100	NULL
ng	NULL
of	NULL
SEE	NULL
per	NULL
ml	NULL
for	NULL
another	NULL
8	NULL
h.	NULL
Cells	NULL
were	NULL
harvested	NULL
32	NULL
h	NULL
posttransfection	NULL
,	NULL
washed	NULL
twice	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
treated	NULL
with	NULL
lysis	NULL
buffer	NULL
(	NULL
luciferase	NULL
assay	NULL
,	NULL
Promega	NULL
)	NULL
for	NULL
5	NULL
to	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

Lysates	NULL
were	NULL
spun	NULL
down	NULL
for	NULL
1	NULL
min	NULL
,	NULL
and	NULL
the	NULL
total	NULL
supernatants	NULL
were	NULL
analyzed	NULL
using	NULL
luciferase	NULL
reagent	NULL
(	NULL
Promega	NULL
)	NULL
and	NULL
measured	NULL
as	NULL
a	NULL
duplicate	NULL
in	NULL
a	NULL
luminometer	NULL
(	NULL
MicroLumat	NULL
LB	NULL
96	NULL
P	NULL
,	NULL
Berthold	NULL
)	NULL
for	NULL
5	NULL
s.	NULL
Background	NULL
measurement	NULL
was	NULL
subtracted	NULL
from	NULL
each	NULL
duplicate	NULL
,	NULL
and	NULL
experimental	NULL
values	NULL
are	NULL
expressed	NULL
either	NULL
as	NULL
recorded	NULL
light	NULL
units	NULL
of	NULL
luciferase	NULL
activity	NULL
or	NULL
as	NULL
relative	NULL
activity	NULL
compared	NULL
with	NULL
extracts	NULL
from	NULL
unstimulated	NULL
cells	NULL
(	NULL
16	NULL
)	NULL
.	NULL

IL-2	NULL
bioassay	NULL
The	NULL
amount	NULL
of	NULL
IL-2	NULL
in	NULL
supernatants	NULL
was	NULL
determined	NULL
in	NULL
a	NULL
microassay	NULL
based	NULL
on	NULL
IL-2-dependent	NULL
proliferation	NULL
of	NULL
the	NULL
CTLL	NULL
murine	NULL
cell	NULL
line	NULL
as	NULL
described	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Results	NULL
B7-1	NULL
costimulation	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
results	NULL
in	NULL
strong	NULL
induction	NULL
of	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l-driven	NULL
reporter	NULL
genes	NULL
and	NULL
high	NULL
levels	NULL
of	NULL
IL-2	NULL
transcription	NULL
,	NULL
while	NULL
LFA-3	NULL
costimulation	NULL
results	NULL
in	NULL
low	NULL
or	NULL
moderate	NULL
activity	NULL
of	NULL
AP-1	NULL
,	NULL
NF-KB	NULL
,	NULL
and	NULL
IL-2	NULL
promoter-driven	NULL
reporter	NULL
genes	NULL
(	NULL
16	NULL
)	NULL
.	NULL

To	NULL
elucidate	NULL
the	NULL
role	NULL
of	NULL
AP-1	NULL
and	NULL
Rel	NULL
proteins	NULL
in	NULL
the	NULL
superinduction	NULL
of	NULL
IL-2	NULL
transcription	NULL
,	NULL
we	NULL
transiently	NULL
overexpressed	NULL
these	NULL
nuclear	NULL
factors	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
studied	NULL
their	NULL
influence	NULL
on	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
and	NULL
multimers	NULL
of	NULL
the	NULL
AP-1	NULL
,	NULL
CD28	NULL
,	NULL
and	NULL
NF-KB	NULL
response	NULL
elements	NULL
using	NULL
reporter	NULL
constructs	NULL
.	NULL

The	NULL
transfected	NULL
Jurkat	NULL
cells	NULL
were	NULL
costimulated	NULL
with	NULL
untransfected	NULL
CHO	NULL
cells	NULL
,	NULL
CHO-DR	NULL
,	NULL
CHO-DR/B7-1	NULL
,	NULL
CHO-DR/	NULL
LFA-3	NULL
,	NULL
and	NULL
CHO-DR/B7-1/LFA-3	NULL
transfectants	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
the	NULL
superantigen	NULL
SEE	NULL
.	NULL

In	NULL
this	NULL
system	NULL
,	NULL
the	NULL
Jurkat	NULL
T	NULL
cells	NULL
receive	NULL
the	NULL
first	NULL
signal	NULL
by	NULL
the	NULL
interaction	NULL
between	NULL
TCR	NULL
and	NULL
the	NULL
SEE/HLA-DR	NULL
complex	NULL
and	NULL
a	NULL
second	NULL
signal	NULL
by	NULL
the	NULL
B7/CD28	NULL
or	NULL
LFA-3/CD2	NULL
pathways	NULL
.	NULL

B7-1	NULL
but	NULL
not	NULL
LFA-3	NULL
costimulation	NULL
superinduces	NULL
IL-2	NULL
production	NULL
Large	NULL
amounts	NULL
of	NULL
IL-2	NULL
were	NULL
produced	NULL
by	NULL
B7-1-costimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SEE	NULL
,	NULL
while	NULL
a	NULL
five-	NULL
to	NULL
sixfold	NULL
amount	NULL
was	NULL
observed	NULL
after	NULL
LFA-3	NULL
costimulation	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Only	NULL
marginal	NULL
production	NULL
was	NULL
seen	NULL
in	NULL
SEE-	NULL
and	NULL
CHO-DR-stimulated	NULL
T	NULL
cells	NULL
.	NULL

Production	NULL
of	NULL
IL-2	NULL
was	NULL
further	NULL
increased	NULL
when	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
costimulated	NULL
with	NULL
the	NULL
triple	NULL
CHO	NULL
transfectant	NULL
(	NULL
CHO-DR/B7-1/	NULL
LFA-3	NULL
)	NULL
,	NULL
indicating	NULL
a	NULL
cooperative	NULL
effect	NULL
between	NULL
B7-1	NULL
and	NULL
LFA-3	NULL
in	NULL
IL-2	NULL
gene	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

c-Jun	NULL
transfection	NULL
partially	NULL
enhances	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
expression	NULL
plasmids	NULL
encoding	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
and	NULL
reporter	NULL
constructs	NULL
containing	NULL
the	NULL
inducible	NULL
region	NULL
of	NULL
the	NULL
IL-2	NULL
enhancer/promoter	NULL
(	NULL
-500	NULL
to	NULL
+60	NULL
)	NULL
or	NULL
an	NULL
AP-1	NULL
reporter	NULL
gene	NULL
.	NULL

B7-1	NULL
costimulation	NULL
was	NULL
required	NULL
to	NULL
induce	NULL
high	NULL
transcription	NULL
of	NULL
these	NULL
constructs	NULL
.	NULL

The	NULL
effect	NULL
observed	NULL
after	NULL
LFA-3	NULL
costimulation	NULL
was	NULL
three-	NULL
to	NULL
fourfold	NULL
lower	NULL
on	NULL
both	NULL
IL-2	NULL
promoter	NULL
and	NULL
AP-l-driven	NULL
transcription	NULL
.	NULL

Marginal	NULL
activity	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
5376	NULL
p65	NULL
AND	NULL
c-Jun	NULL
OVEREXPRESSION	NULL
SUPERINDUCE	NULL
IL-2	NULL
PROMOTER	NULL
ACTIVITY	NULL
{	NULL
cHo	NULL
&	NULL
cHoO-DRr	NULL
CHO-DR/LFA-3	NULL
200	NULL
C	NULL
cho-DRB7A	NULL
_	NULL
BB	NULL
CHO-DR/AB7-ULFA-3	NULL
1507	NULL
£	NULL
-	NULL
1007	NULL
in	NULL
H	NULL
R	NULL
50	NULL
4	NULL
0	NULL
-	NULL
:	NULL
Control	NULL
SEE	NULL
100	NULL
ng/ml	NULL
FIGURE	NULL
1	NULL
.	NULL

Costimulatory	NULL
effects	NULL
of	NULL
B7-1	NULL
and	NULL
LFA-3	NULL
in	NULL
induction	NULL
of	NULL
IL-2	NULL
production	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
(	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
were	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
with	NULL
CHO	NULL
(	NULL
untransfected	NULL
)	NULL
and	NULL
CHO-DR	NULL
,	NULL
CHO-DR/B7-1	NULL
,	NULL
CHO-DR/	NULL
LEFA-3	NULL
,	NULL
or	NULL
CHO-DR/B7-1/LFA-3-transfected	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
with	NULL
or	NULL
without	NULL
SEE	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL

1	NULL
)	NULL
.	NULL

Error	NULL
bars	NULL
indicate	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

was	NULL
induced	NULL
by	NULL
HL-A-DR	NULL
stimulation	NULL
alone	NULL
.	NULL

These	NULL
results	NULL
correlated	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
protein	NULL
production	NULL
presented	NULL
in	NULL
Figure	NULL
1	NULL
.	NULL

Overexpression	NULL
of	NULL
c-Jun	NULL
slightly	NULL
enhanced	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
and	NULL
AP-1	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
reporter	NULL
gene	NULL
constructs	NULL
.	NULL

Cotransfection	NULL
of	NULL
a	NULL
c-Fos	NULL
expression	NULL
vector	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
and	NULL
AP-1	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
reporter	NULL
constructs	NULL
.	NULL

A	NULL
substantial	NULL
increase	NULL
in	NULL
IL-2	NULL
promoter	NULL
and	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
was	NULL
observed	NULL
after	NULL
combined	NULL
cotransfection	NULL
of	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
.	NULL

Interestingly	NULL
,	NULL
AP-1-driven	NULL
transcription	NULL
in	NULL
c-Fos/c-Jun-transfected	NULL
Jurkat	NULL
cells	NULL
was	NULL
dramatically	NULL
augmented	NULL
in	NULL
DR	NULL
and	NULL
DR/LFA-3-stimulated	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Ap-parently	NULL
,	NULL
a	NULL
proper	NULL
signal	NULL
is	NULL
required	NULL
to	NULL
induce	NULL
AP-1	NULL
reporter	NULL
activity	NULL
in	NULL
Jun/Fos-transfected	NULL
T	NULL
cells	NULL
,	NULL
since	NULL
no	NULL
activity	NULL
was	NULL
seen	NULL
in	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
with	NULL
CHO/SEE	NULL
alone	NULL
.	NULL

p65	NULL
overexpression	NULL
augments	NULL
transcription	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
CD28RE	NULL
reporter	NULL
constructs	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
To	NULL
explore	NULL
whether	NULL
overexpression	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
proteins	NULL
p50	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
Rel	NULL
A	NULL
influences	NULL
transcriptional	NULL
activity	NULL
of	NULL
IL-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
-	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
-	NULL
,	NULL
and	NULL
CD28RE	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
-driven	NULL
reporter	NULL
genes	NULL
,	NULL
cotransfection	NULL
assays	NULL
with	NULL
expression	NULL
vectors	NULL
encoding	NULL
the	NULL
Rel	NULL
family	NULL
proteins	NULL
and	NULL
reporter	NULL
gene	NULL
constructs	NULL
were	NULL
performed	NULL
.	NULL

The	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
,	NULL
NF-KB	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
,	NULL
and	NULL
CD28RE	NULL
reporter	NULL
constructs	NULL
was	NULL
augmented	NULL
by	NULL
B7-1	NULL
and	NULL
B7-1/LFA-3	NULL
costimulation	NULL
,	NULL
while	NULL
the	NULL
activity	NULL
induced	NULL
by	NULL
LFA-3	NULL
was	NULL
low	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Marginal	NULL
or	NULL
no	NULL
induction	NULL
was	NULL
observed	NULL
after	NULL
HLA-DR	NULL
stimulation	NULL
alone	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
expressed	NULL
by	NULL
the	NULL
CD28RE-driven	NULL
reporter	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
was	NULL
low	NULL
,	NULL
compared	NULL
with	NULL
the	NULL
luciferase	NULL
activity	NULL
expressed	NULL
by	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
and	NULL
NF-KB	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
reporter	NULL
constructs	NULL
.	NULL

Overexpression	NULL
of	NULL
p50	NULL
and	NULL
c-Rel	NULL
had	NULL
marginal	NULL
and	NULL
low	NULL
effects	NULL
,	NULL
respectively	NULL
,	NULL
on	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
and	NULL
NF-KB	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
reporter	NULL
constructs	NULL
.	NULL

Cotransfection	NULL
of	NULL
p65	NULL
expression	NULL
plasmids	NULL
resulted	NULL
in	NULL
a	NULL
moderate	NULL
to	NULL
strong	NULL
increase	NULL
in	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
,	NULL
and	NULL
CD28RE	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
reporter	NULL
genes	NULL
in	NULL
B7-1-	NULL
and	NULL
LFA-3-costimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
dramatic	NULL
effect	NULL
of	NULL
the	NULL
p65	NULL
proteins	NULL
on	NULL
the	NULL
frans-activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
reporter	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
in	NULL
DR/LFA-3-costimulated	NULL
T	NULL
cells	NULL
was	NULL
ob-served	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
similar	NULL
activity	NULL
as	NULL
in	NULL
B7-1-costimulated	NULL
T	NULL
cells	NULL
.	NULL

More	NULL
interestingly	NULL
,	NULL
a	NULL
dramatic	NULL
transcriptional	NULL
increase	NULL
was	NULL
observed	NULL
after	NULL
cotransfection	NULL
of	NULL
CD28RE	NULL
reporter	NULL
construct	NULL
and	NULL
the	NULL
p65	NULL
expression	NULL
plasmid	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
was	NULL
CHO	NULL
a	NULL
CHO-DR	NULL
CHO-DR/LFA-3	NULL
[	NULL
(	NULL
I	NULL
CHO-DR/B71	NULL
ER	NULL
_	NULL
CHO-DR/B7-1/LEA-3	NULL
5	NULL
A	NULL
IL-2	NULL
p-Lue	NULL
Luciferase	NULL
Activity	NULL
(	NULL
RLU	NULL
x	NULL
10	NULL
S	NULL
)	NULL
+	NULL
c-Fos	NULL
+	NULL
c-Jun	NULL
+	NULL
c-Jun/c-Fos	NULL
Expression	NULL
Vector	NULL
(	NULL
s	NULL
)	NULL
10	NULL
B	NULL
4x	NULL
AP-1-Lue	NULL
co	NULL
i	NULL
Luciferase	NULL
activity	NULL
(	NULL
RLUX104	NULL
)	NULL
+	NULL
e-Fos/c-Jun	NULL
+	NULL
c-Fos	NULL
+	NULL
c-Jun	NULL
Expression	NULL
Vector	NULL
(	NULL
s	NULL
)	NULL
FIGURE	NULL
2	NULL
.	NULL

-	NULL
frans-Activation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
and	NULL
a	NULL
multimer	NULL
of	NULL
the	NULL
AP-1	NULL
reporter	NULL
construct	NULL
by	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
.	NULL

A	NULL
,	NULL
frans-Activation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
by	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
cotransfected	NULL
with	NULL
c-Fos	NULL
and/or	NULL
c-Jun	NULL
expression	NULL
vectors	NULL
,	NULL
together	NULL
with	NULL
the	NULL
human	NULL
IL-2	NULL
promoter-luciferase	NULL
reporter	NULL
plasmid	NULL
(	NULL
-500	NULL
to	NULL
+60	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Effects	NULL
of	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
expression	NULL
vectors	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
multimer	NULL
of	NULL
AP-1	NULL
consensus	NULL
site	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
cotransfected	NULL
with	NULL
c-Fos	NULL
and/or	NULL
c-Jun	NULL
expression	NULL
vectors	NULL
,	NULL
together	NULL
with	NULL
a	NULL
reporter	NULL
construct	NULL
containing	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
AP-1	NULL
consensus	NULL
sequence	NULL
(	NULL
4XCGATTGAGTCAGGGTA	NULL
ACG	NULL
)	NULL
fused	NULL
to	NULL
the	NULL
rat	NULL
prolactin	NULL
minimal	NULL
promoter	NULL
(	NULL
-36	NULL
to	NULL
+37	NULL
)	NULL
minimal	NULL
promoter	NULL
,	NULL
then	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SEE	NULL
and	NULL
CHO	NULL
(	NULL
untransfected	NULL
)	NULL
,	NULL
CHO-DR	NULL
,	NULL
CHO-DR/B7-1	NULL
,	NULL
CHO-DR/LFA-3	NULL
,	NULL
and	NULL
CHO-DR/B7-1/LFA-3	NULL
transfectants	NULL
24	NULL
h	NULL
posttransfection	NULL
.	NULL

Luciferase	NULL
activity	NULL
is	NULL
expressed	NULL
as	NULL
arbitrary	NULL
light	NULL
units	NULL
(	NULL
RLU	NULL
)	NULL
minus	NULL
background	NULL
units	NULL
of	NULL
buffer	NULL
alone	NULL
.	NULL

Both	NULL
sets	NULL
of	NULL
results	NULL
shown	NULL
are	NULL
mean	NULL
values	NULL
from	NULL
three	NULL
similar	NULL
experiments	NULL
.	NULL

Error	NULL
bars	NULL
indicate	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

increased	NULL
about	NULL
30-	NULL
to	NULL
40-fold	NULL
with	NULL
p65	NULL
in	NULL
DR-	NULL
,	NULL
DR-B7-1-	NULL
,	NULL
DR-LFA-3-	NULL
,	NULL
and	NULL
DR-B7-1/LFA-3-costimulated	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
CD28RE	NULL
activity	NULL
in	NULL
p65	NULL
expressing	NULL
Jurkat	NULL
cells	NULL
remained	NULL
at	NULL
2.5	NULL
to	NULL
threefold	NULL
lower	NULL
levels	NULL
when	NULL
costimulated	NULL
with	NULL
LFA-3	NULL
compared	NULL
with	NULL
B7-1	NULL
.	NULL

c-Rel	NULL
transfection	NULL
increased	NULL
only	NULL
two-	NULL
to	NULL
threefold	NULL
the	NULL
CD28RE-dependent	NULL
frams-activation	NULL
,	NULL
whereas	NULL
p50	NULL
transfection	NULL
failed	NULL
to	NULL
influence	NULL
CD28RE	NULL
transcription	NULL
.	NULL

Combined	NULL
transcription	NULL
of	NULL
c-Jun	NULL
with	NULL
p65	NULL
or	NULL
c-Rel	NULL
strongly	NULL
up-regulates	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
To	NULL
determine	NULL
whether	NULL
overexpression	NULL
of	NULL
AP-1	NULL
and	NULL
Rel	NULL
proteins	NULL
cooperate	NULL
to	NULL
regulate	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
inducible	NULL
IL-2	NULL
promoter	NULL
,	NULL
we	NULL
performed	NULL
cotransfection	NULL
assays	NULL
with	NULL
the	NULL
IL-2	NULL
promoter	NULL
reporter	NULL
construct	NULL
and	NULL
p65	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
,	NULL
c-Rel	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
,	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
expression	NULL
plasmids	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
coexpression	NULL
of	NULL
p65	NULL
with	NULL
c-Jun	NULL
dramatically	NULL
enhanced	NULL
the	NULL
IL-2	NULL
promoter	NULL
activity	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
E	NULL
CHO	NULL
CHO-DR	NULL
CHO-DR/LFA-3	NULL
CJ	NULL
_CHO-DR/B7-1	NULL
A	NULL
P-Lue	NULL
EH	NULL
_	NULL
CHO-DR/B7-1/LFA-3	NULL
Luciferase	NULL
Activity	NULL
(	NULL
RLU	NULL
x	NULL
104	NULL
)	NULL
+p50	NULL
+	NULL
cRel	NULL
+	NULL
p65	NULL
B	NULL
2x	NULL
NF-kB-Lue	NULL
Luciferase	NULL
Activity	NULL
(	NULL
RLU	NULL
x	NULL
105	NULL
)	NULL
+p50	NULL
+	NULL
c-Rel	NULL
+	NULL
p65	NULL
40	NULL
C	NULL
4x	NULL
CD28RE-Luc	NULL
Luciferase	NULL
Activity	NULL
(	NULL
RLU	NULL
x	NULL
10	NULL
3	NULL
+	NULL
p50	NULL
+	NULL
c-Rel	NULL
+	NULL
p65	NULL
Expression	NULL
Vector	NULL
(	NULL
s	NULL
)	NULL
FIGURE	NULL
3.	NULL
frans-Activation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
and	NULL
multimers	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
CD28RE	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
by	NULL
p50	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
p65	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
cotransfected	NULL
with	NULL
p50	NULL
,	NULL
c-Rel	NULL
,	NULL
or	NULL
p65	NULL
expression	NULL
vectors	NULL
,	NULL
together	NULL
with	NULL
luciferase	NULL
reporter	NULL
plasmids	NULL
driven	NULL
by	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
(	NULL
-500	NULL
to	NULL
+60	NULL
)	NULL
(	NULL
A	NULL
)	NULL
,	NULL
a	NULL
tandem	NULL
repeat	NULL
of	NULL
the	NULL
pNF-	NULL
«	NULL
B	NULL
(	NULL
two	NULL
copies	NULL
of	NULL
NF-kB	NULL
;	NULL
GGGACTTTCC	NULL
consensus	NULL
)	NULL
(	NULL
B	NULL
)	NULL
,	NULL
or	NULL
a	NULL
multimer	NULL
of	NULL
the	NULL
pCD28RE-	NULL
(	NULL
four	NULL
copies	NULL
of	NULL
CD28RE	NULL
;	NULL
AAAGAAATTCC	NULL
)	NULL
(	NULL
C	NULL
)	NULL
and	NULL
cultured	NULL
in	NULL
presence	NULL
of	NULL
SEE	NULL
and	NULL
the	NULL
CHO	NULL
(	NULL
untransfected	NULL
)	NULL
,	NULL
CHO-DR	NULL
,	NULL
CHO-DR/B7-1	NULL
,	NULL
CHO-DR/LFA-3	NULL
,	NULL
and	NULL
CHO-DR/B7-1/LFA-3	NULL
transfectants	NULL
24	NULL
h	NULL
posttransfection	NULL
.	NULL

Luciferase	NULL
activity	NULL
is	NULL
expressed	NULL
as	NULL
RLU	NULL
minus	NULL
background	NULL
units	NULL
of	NULL
buffer	NULL
alone	NULL
.	NULL

All	NULL
sets	NULL
of	NULL
results	NULL
shown	NULL
are	NULL
mean	NULL
values	NULL
from	NULL
three	NULL
similar	NULL
experiments	NULL
.	NULL

Error	NULL
bars	NULL
indicate	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
whereas	NULL
c-Jun/c-Rel	NULL
moderately	NULL
influenced	NULL
the	NULL
activity	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
expression	NULL
of	NULL
c-Fos	NULL
suppressed	NULL
the	NULL
potent	NULL
frans-activation	NULL
by	NULL
p65	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
but	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
increase	NULL
induced	NULL
by	NULL
c-Rel	NULL
and	NULL
c-Rel/c-Jun	NULL
coexpression	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
LFA-3	NULL
costimulation	NULL
of	NULL
p65/c-Jun	NULL
cotransfected	NULL
cells	NULL
induced	NULL
>	NULL
20-fold	NULL
increase	NULL
in	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
resulting	NULL
in	NULL
levels	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
B7-1-costimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

Reporter	NULL
constructs	NULL
carrying	NULL
multimers	NULL
of	NULL
CD28RE/AP-1	NULL
sites	NULL
are	NULL
synergistically	NULL
stimulated	NULL
by	NULL
B7-1	NULL
and	NULL
B7-1/LFA-3	NULL
Previous	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
the	NULL
IL-2	NULL
promoter	NULL
proxi-mal	NULL
AP-1-binding	NULL
site	NULL
influences	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
CD28RE	NULL
(	NULL
35	NULL
,	NULL
50	NULL
,	NULL
51	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
cis-acting	NULL
AP-1	NULL
site	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
could	NULL
influence	NULL
the	NULL
moderate	NULL
luciferase	NULL
ac	NULL
5377	NULL
m	NULL
cho	NULL
E	NULL
»	NULL
cHO-DR	NULL
CHO-DRLFA-3	NULL
so	NULL
C	NULL
_	NULL
CHO-DR/B7-1	NULL
_	NULL
W	NULL
CHO-DR/B7-U/LFA-3	NULL
A	NULL
IL-2	NULL
P-Lue	NULL
Luciferase	NULL
Activity	NULL
(	NULL
RLU	NULL
x	NULL
10	NULL
3	NULL
65	NULL
yos	NULL
ju8	NULL
[	NULL
359	NULL
*P	NULL
,	NULL
peste	NULL
,	NULL
poot	NULL
?	NULL

“	NULL
Wovosu	NULL
Expression	NULL
Vector	NULL
(	NULL
s	NULL
)	NULL
25	NULL
IL-2	NULL
P-Lue	NULL
20	NULL
157	NULL
Luciferase	NULL
Activity	NULL
(	NULL
RLU	NULL
x	NULL
10	NULL
z	NULL
I	NULL
'll	NULL
)	NULL
A	NULL
¢	NULL
m	NULL
,	NULL
e®	NULL
we	NULL
rol	NULL
R	NULL
33°	NULL
“	NULL
c	NULL
Expression	NULL
Vector	NULL
(	NULL
s	NULL
)	NULL
FIGURE	NULL
4	NULL
.	NULL

Effect	NULL
of	NULL
the	NULL
combined	NULL
action	NULL
of	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
c-Jun	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
-500	NULL
to	NULL
+60	NULL
)	NULL
luciferase	NULL
reporter	NULL
construct	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
cotransfected	NULL
with	NULL
p65	NULL
,	NULL
p65/c-Fos	NULL
,	NULL
p65/c-Jun	NULL
,	NULL
and	NULL
p65/c-Fos/c-Jun	NULL
expression	NULL
vectors	NULL
(	NULL
A	NULL
)	NULL
or	NULL
c-Rel	NULL
,	NULL
c-Rel/c-Fos	NULL
c-Rel/c-Jun	NULL
and	NULL
c-Rel/c-Fos/c-Jun	NULL
expression	NULL
vectors	NULL
(	NULL
B	NULL
)	NULL
,	NULL
together	NULL
with	NULL
the	NULL
human	NULL
IL-2	NULL
promoter-luciferase	NULL
reporter	NULL
plasmid	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
the	NULL
transfected	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
presence	NULL
of	NULL
SEE	NULL
and	NULL
the	NULL
CHO	NULL
(	NULL
untransfected	NULL
)	NULL
,	NULL
CHO-DR	NULL
,	NULL
CHO-DR/B7-1	NULL
,	NULL
CHO-DR/LFA-3	NULL
,	NULL
and	NULL
CHO-DR/B7-1/LFA-3	NULL
transfectants	NULL
.	NULL

Both	NULL
sets	NULL
of	NULL
results	NULL
shown	NULL
are	NULL
mean	NULL
values	NULL
from	NULL
three	NULL
similar	NULL
experiments	NULL
.	NULL

Error	NULL
bars	NULL
indicate	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

tivity	NULL
expressed	NULL
by	NULL
reporter	NULL
construct	NULL
containing	NULL
the	NULL
multimer	NULL
of	NULL
the	NULL
CD28RE	NULL
,	NULL
we	NULL
used	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
containing	NULL
a	NULL
multimer	NULL
of	NULL
a	NULL
linked	NULL
CD28RE-AP-1	NULL
(	NULL
wild-type	NULL
)	NULL
construct	NULL
and	NULL
a	NULL
panel	NULL
of	NULL
substitution	NULL
mutants	NULL
,	NULL
including	NULL
CD28REmt-AP-1	NULL
(	NULL
CD28RE	NULL
mutant	NULL
)	NULL
,	NULL
CD28RE-AP-1	NULL
mt	NULL
(	NULL
AP-1	NULL
mutant	NULL
)	NULL
,	NULL
and	NULL
CD28REmt-AP-1	NULL
mt	NULL
(	NULL
CD28RE-AP-1	NULL
double	NULL
mutant	NULL
)	NULL
.	NULL

The	NULL
pGL-2	NULL
vector	NULL
was	NULL
used	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
CD28RE/AP-1	NULL
(	NULL
wild-type	NULL
)	NULL
responded	NULL
strongly	NULL
to	NULL
costimulation	NULL
induced	NULL
by	NULL
B7-1	NULL
and	NULL
B7-1/LFA-3	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
mutations	NULL
introduced	NULL
into	NULL
the	NULL
CD28RE	NULL
only	NULL
marginally	NULL
affected	NULL
the	NULL
activity	NULL
induced	NULL
by	NULL
DR/LFA-3	NULL
but	NULL
strongly	NULL
reduced	NULL
the	NULL
response	NULL
to	NULL
B7-1	NULL
costimulation	NULL
.	NULL

The	NULL
AP-1	NULL
mutation	NULL
reduced	NULL
the	NULL
response	NULL
dramatically	NULL
after	NULL
B7-1	NULL
costimulation	NULL
and	NULL
moderately	NULL
after	NULL
LFA-3	NULL
costimulation	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
expressed	NULL
by	NULL
either	NULL
the	NULL
CD28REmt	NULL
or	NULL
the	NULL
AP-1	NULL
mt	NULL
is	NULL
grossly	NULL
in	NULL
the	NULL
same	NULL
range	NULL
as	NULL
the	NULL
activity	NULL
expressed	NULL
by	NULL
the	NULL
reporter	NULL
construct	NULL
multimers	NULL
of	NULL
AP-1	NULL
or	NULL
CD28RE	NULL
sites	NULL
alone	NULL
in	NULL
this	NULL
system	NULL
.	NULL

The	NULL
linkage	NULL
of	NULL
the	NULL
CD28RE/AP-1	NULL
site	NULL
creates	NULL
a	NULL
strong	NULL
transcriptional	NULL
reporter	NULL
gene	NULL
activity	NULL
in	NULL
B7-1-costimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
supports	NULL
the	NULL
hypothesis	NULL
of	NULL
cooperative	NULL
effects	NULL
between	NULL
these	NULL
cis-acting	NULL
sites	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
5378	NULL
p65	NULL
AND	NULL
c-Jun	NULL
OVEREXPRESSION	NULL
SUPERINDUCE	NULL
IL-2	NULL
PROMOTER	NULL
ACTIVITY	NULL
C	NULL
CHO	NULL
CHO-DR	NULL
CHO-DRLFA-3	NULL
CG	NULL
_CHO-DRB7-1	NULL
_	NULL
M	NULL
_CHO-DR/B7-ULEFA-3	NULL
A	NULL
m	NULL
S	NULL
ra	NULL
1	NULL
co	NULL
A	NULL
Luciferase	NULL
Activity	NULL
(	NULL
RLU	NULL
x	NULL
10	NULL
4	NULL
)	NULL
&	NULL
&	NULL
p	NULL
--	NULL
a	NULL
-o	NULL
~	NULL
vr	NULL
¢	NULL
Z	NULL
CD28RE/AP-1	NULL
wt	NULL
pCL-2	NULL
CD2SRE	NULL
mUAP-1	NULL
mt	NULL
AP-1	NULL
mt	NULL
CD28RE	NULL
mt	NULL
Vector	NULL
(	NULL
s	NULL
)	NULL
FIGURE	NULL
5	NULL
.	NULL

Synergistic	NULL
effect	NULL
of	NULL
CD28RE/AP-1	NULL
IL-2	NULL
sequence	NULL
in	NULL
response	NULL
to	NULL
CHO-DR/B7-1	NULL
and	NULL
CHO-DR/B7-1/LFA-3	NULL
transfectants	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
pGL-2	NULL
basic	NULL
plasmid	NULL
,	NULL
the	NULL
pGL-2-CD28REmt/AP-1	NULL
mt	NULL
(	NULL
double	NULL
mutant	NULL
)	NULL
,	NULL
the	NULL
mt	NULL
(	NULL
AP-1	NULL
single	NULL
mutant	NULL
)	NULL
,	NULL
the	NULL
CD28REmt/AP-1wt	NULL
(	NULL
CD28RE	NULL
single	NULL
mutant	NULL
)	NULL
,	NULL
or	NULL
the	NULL
wild-type	NULL
CD28RE/AP-1	NULL
luciferase	NULL
reporter	NULL
plasmids	NULL
for	NULL
24	NULL
h.	NULL
The	NULL
transfected	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
subsequently	NULL
cultured	NULL
in	NULL
presence	NULL
of	NULL
SEE	NULL
and	NULL
the	NULL
CHO	NULL
(	NULL
untransfected	NULL
)	NULL
,	NULL
CHO-DR	NULL
,	NULL
CHO-DR/B7-1	NULL
,	NULL
CHO-DR/	NULL
LFA-3	NULL
and	NULL
CHO-DR/B7-1/LFA-3	NULL
transfectants	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
are	NULL
mean	NULL
values	NULL
from	NULL
three	NULL
similar	NULL
experiments	NULL
.	NULL

Error	NULL
bars	NULL
indicate	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

CD28RE/AP-1-driven	NULL
transcription	NULL
is	NULL
enhanced	NULL
by	NULL
overexpression	NULL
of	NULL
p6S5/c-Jun	NULL
To	NULL
determine	NULL
whether	NULL
the	NULL
combined	NULL
action	NULL
of	NULL
p65	NULL
and	NULL
c-Jun	NULL
could	NULL
cooperate	NULL
to	NULL
up-regulate	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
CD28RE/AP-1	NULL
reporter	NULL
construct	NULL
,	NULL
we	NULL
transiently	NULL
expressed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
the	NULL
CD28RE/AP-1	NULL
reporter	NULL
construct	NULL
with	NULL
p65	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
c-Jun	NULL
expression	NULL
plasmids	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
costimulated	NULL
with	NULL
DR	NULL
,	NULL
DR/B7-1	NULL
,	NULL
DR/LFA-3	NULL
,	NULL
and	NULL
DR/B7-1/	NULL
LFA-3	NULL
was	NULL
moderately	NULL
increased	NULL
by	NULL
p65	NULL
and	NULL
strongly	NULL
increased	NULL
by	NULL
the	NULL
combined	NULL
action	NULL
of	NULL
p65/c-Jun	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
A	NULL
functional	NULL
CD28RE	NULL
is	NULL
required	NULL
for	NULL
p65/c-IJun-mediated	NULL
superinduction	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
To	NULL
study	NULL
whether	NULL
the	NULL
p65-	NULL
and	NULL
p65/c-Jun	NULL
mediated	NULL
superinduction	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
promoter	NULL
involved	NULL
the	NULL
CD28RE	NULL
,	NULL
we	NULL
performed	NULL
cotransfection	NULL
assays	NULL
with	NULL
wild-type	NULL
IL-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

74	NULL
)	NULL
and	NULL
CD28RE-mutated	NULL
IL-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
together	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
p65	NULL
,	NULL
c-Fos	NULL
,	NULL
c-Jun	NULL
,	NULL
and	NULL
the	NULL
combination	NULL
of	NULL
c-Fos/p65	NULL
and	NULL
c-Jun/p65	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
was	NULL
strongly	NULL
reduced	NULL
in	NULL
the	NULL
IL-2	NULL
mutant	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
,	NULL
and	NULL
the	NULL
coexpression	NULL
of	NULL
p65/c-Jun	NULL
only	NULL
marginally	NULL
influenced	NULL
this	NULL
response	NULL
and	NULL
failed	NULL
to	NULL
restore	NULL
the	NULL
transcriptional	NULL
activity	NULL
.	NULL

These	NULL
data	NULL
demonstrated	NULL
the	NULL
requirement	NULL
for	NULL
a	NULL
functional	NULL
CD28RE	NULL
to	NULL
superinduce	NULL
IL-2	NULL
transcription	NULL
in	NULL
p65/c-Jun-stimulated	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
requirement	NULL
was	NULL
further	NULL
demonstrated	NULL
with	NULL
an	NULL
IL-2	NULL
promoter	NULL
wild-type	NULL
(	NULL
Fig	NULL
.	NULL

84	NULL
)	NULL
and	NULL
an	NULL
IL-2	NULL
promoter	NULL
bearing	NULL
a	NULL
mutation	NULL
at	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

The	NULL
results	NULL
demonstrated	NULL
that	NULL
the	NULL
transcriptional	NULL
activity	NULL
in	NULL
the	NULL
mutated	NULL
IL-2	NULL
promoter	NULL
was	NULL
diminished	NULL
by	NULL
30	NULL
%	NULL
,	NULL
and	NULL
it	NULL
could	NULL
not	NULL
only	NULL
be	NULL
restored	NULL
but	NULL
also	NULL
be	NULL
superinduced	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
c-Jun/p65	NULL
.	NULL

Discussion	NULL
B7-1	NULL
and	NULL
LFA-3	NULL
provide	NULL
costimulatory	NULL
signals	NULL
to	NULL
T	NULL
cells	NULL
promoting	NULL
T	NULL
cells	NULL
proliferation	NULL
and	NULL
cytokine	NULL
production	NULL
.	NULL

However	NULL
,	NULL
the	NULL
profile	NULL
of	NULL
B7-1	NULL
and	NULL
LFA-3	NULL
costimulated	NULL
cells	NULL
differ	NULL
markedly	NULL
.	NULL

C	NULL
cHo	NULL
&	NULL
a	NULL
CHO-DR	NULL
CHO-DR/ILFA-3	NULL
C	NULL
CHO-DR/B7-L	NULL
-	NULL
MB	NULL
CHO-DR/B7-ULFA-3	NULL
20	NULL
CD28RE-AP-1-Lue	NULL
15	NULL
7	NULL
10	NULL
7	NULL
Luciferase	NULL
Activity	NULL
(	NULL
RLUx10	NULL
4	NULL
)	NULL
has	NULL
Z	NULL
ta	NULL
y8®	NULL
65	NULL
-	NULL
ge	NULL
aP	NULL
a	NULL
965K	NULL
a	NULL
v55K	NULL
a	NULL
“	NULL
ash-You	NULL
Expression	NULL
Vector	NULL
(	NULL
s	NULL
)	NULL
FIGURE	NULL
6	NULL
.	NULL

-	NULL
Superinduction	NULL
of	NULL
the	NULL
CD28RE-AP-1	NULL
sequence	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
by	NULL
overexpression	NULL
of	NULL
p65/c-Jun	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
pCD28RE/AP-l-luciferase	NULL
reporter	NULL
gene	NULL
together	NULL
with	NULL
p65	NULL
,	NULL
p65/c-Fos	NULL
,	NULL
p65/c-Jun	NULL
,	NULL
and	NULL
p65/c-Fos/c-Jun	NULL
expression	NULL
vectors	NULL
for	NULL
24	NULL
h.	NULL
The	NULL
transfected	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
subsequently	NULL
cultured	NULL
in	NULL
presence	NULL
of	NULL
SEE	NULL
and	NULL
the	NULL
CHO	NULL
(	NULL
untransfected	NULL
)	NULL
,	NULL
CHO-DR	NULL
,	NULL
CHO-DR/B7-1	NULL
,	NULL
CHO-DR/LFA-3	NULL
,	NULL
and	NULL
CHO-DR/B7-1/LFA-3	NULL
transfectants	NULL
.	NULL

Luciferase	NULL
activity	NULL
is	NULL
expressed	NULL
as	NULL
RLU	NULL
minus	NULL
background	NULL
units	NULL
of	NULL
buffer	NULL
alone	NULL
.	NULL

Both	NULL
sets	NULL
of	NULL
results	NULL
shown	NULL
are	NULL
mean	NULL
values	NULL
from	NULL
three	NULL
similar	NULL
experiments	NULL
.	NULL

Error	NULL
bars	NULL
indicate	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

B7-1	NULL
is	NULL
a	NULL
potent	NULL
inducer	NULL
of	NULL
IL-2	NULL
production	NULL
and	NULL
sustained	NULL
T	NULL
cell	NULL
growth	NULL
,	NULL
whereas	NULL
LFA-3	NULL
induces	NULL
low	NULL
amounts	NULL
of	NULL
IL-2	NULL
and	NULL
autocrine	NULL
transient	NULL
T	NULL
cell	NULL
proliferation	NULL
.	NULL

However	NULL
,	NULL
high	NULL
levels	NULL
of	NULL
IL-2	NULL
production	NULL
in	NULL
CD2-costimulated	NULL
T	NULL
cells	NULL
has	NULL
been	NULL
demonstrated	NULL
by	NULL
other	NULL
studies	NULL
(	NULL
5	NULL
,	NULL
11	NULL
,	NULL
52	NULL
)	NULL
.	NULL

The	NULL
reasons	NULL
for	NULL
this	NULL
discrepancy	NULL
may	NULL
reflect	NULL
the	NULL
use	NULL
of	NULL
nonphysiologic	NULL
ligands	NULL
,	NULL
such	NULL
as	NULL
PMA	NULL
,	NULL
calcium	NULL
ionophore	NULL
or	NULL
mAbs	NULL
to	NULL
induce	NULL
the	NULL
signals	NULL
into	NULL
the	NULL
T	NULL
cells	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
B7-1	NULL
costimulation	NULL
induced	NULL
higher	NULL
levels	NULL
of	NULL
AP-1-and	NULL
Rel-dependent	NULL
transcription	NULL
compared	NULL
with	NULL
LFA-3	NULL
costimulation	NULL
(	NULL
16	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
NF-AT	NULL
binding	NULL
activity	NULL
were	NULL
higher	NULL
after	NULL
LFA-3	NULL
costimulation	NULL
(	NULL
16	NULL
)	NULL
.	NULL

We	NULL
also	NULL
demonstrated	NULL
that	NULL
CD2	NULL
and	NULL
CD28	NULL
activation	NULL
induced	NULL
different	NULL
patterns	NULL
of	NULL
NF-AT	NULL
complexes	NULL
and	NULL
NF-AT-associated	NULL
proteins	NULL
(	NULL
16	NULL
)	NULL
,	NULL
indicating	NULL
an	NULL
additional	NULL
signaling	NULL
pathway	NULL
following	NULL
CD2	NULL
triggering	NULL
.	NULL

The	NULL
role	NULL
of	NULL
CD2	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
NF-AT	NULL
has	NULL
been	NULL
demonstrated	NULL
by	NULL
Denger	NULL
(	NULL
T.	NULL
J.	NULL
Denger	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

He	NULL
showed	NULL
that	NULL
anti-CD2	NULL
and	NULL
anti-CD48	NULL
mAbs	NULL
in	NULL
combination	NULL
with	NULL
cyclosporin	NULL
A	NULL
act	NULL
synergistically	NULL
to	NULL
induce	NULL
immunosuppression	NULL
and	NULL
graft	NULL
survival	NULL
,	NULL
suggesting	NULL
a	NULL
direct	NULL
relationship	NULL
between	NULL
anti-CD2	NULL
mAbs	NULL
and	NULL
CsA	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
NF-AT	NULL
.	NULL

In	NULL
this	NULL
work	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
overexpression	NULL
of	NULL
c-Jun	NULL
and	NULL
p65	NULL
nuclear	NULL
factors	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
superinduces	NULL
IL-2	NULL
production	NULL
in	NULL
LFA-3-costimulated	NULL
T	NULL
cells	NULL
.	NULL

Overexpression	NULL
of	NULL
c-Jun	NULL
or	NULL
p65	NULL
alone	NULL
only	NULL
moderately	NULL
enhanced	NULL
IL-2	NULL
promoter	NULL
activity	NULL
in	NULL
LFA-3-costimulated	NULL
cells	NULL
,	NULL
whereas	NULL
coexpression	NULL
of	NULL
these	NULL
proteins	NULL
strongly	NULL
augmented	NULL
IL-2	NULL
activity	NULL
in	NULL
LFA-3-costimulated	NULL
cells	NULL
and	NULL
induced	NULL
transcriptional	NULL
levels	NULL
severalfold	NULL
higher	NULL
than	NULL
the	NULL
levels	NULL
seen	NULL
in	NULL
B7-1-costimulated	NULL
untransfected	NULL
T	NULL
cells	NULL
.	NULL

Indeed	NULL
,	NULL
c-Jun/	NULL
p65-expressing	NULL
T	NULL
cells	NULL
transcribed	NULL
the	NULL
IL-2	NULL
promoter	NULL
during	NULL
LFA-3	NULL
costimulation	NULL
almost	NULL
as	NULL
efficiently	NULL
as	NULL
during	NULL
B7-1	NULL
costimulation	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
Fos/Jun	NULL
and	NULL
Rel	NULL
proteins	NULL
to	NULL
cross-couple	NULL
and	NULL
potentiate	NULL
transcription	NULL
has	NULL
been	NULL
reported	NULL
also	NULL
in	NULL
other	NULL
systems	NULL
(	NULL
46	NULL
,	NULL
53	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
combined	NULL
action	NULL
of	NULL
p65/c-Jun	NULL
was	NULL
unable	NULL
to	NULL
substantially	NULL
improve	NULL
the	NULL
low	NULL
luciferase	NULL
activity	NULL
observed	NULL
in	NULL
an	NULL
IL-2	NULL
promoter	NULL
reporter	NULL
construct	NULL
containing	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
CD28RE	NULL
site	NULL
but	NULL
strongly	NULL
induced	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
a	NULL
NF-	NULL
«	NULL
B-mutated	NULL
IL-2	NULL
promoter	NULL
,	NULL
suggesting	NULL
a	NULL
requirement	NULL
for	NULL
an	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
L	NULL
]	NULL
CHO	NULL
CHO-DR	NULL
C	NULL
CHO-DR/B7-1	NULL
CHO-DR/LFA-3	NULL
EN	NULL
CHO-DR/B7-1LFA-3	NULL
IL-2	NULL
P-wt-Lue	NULL
Luciferase	NULL
Activity	NULL
(	NULL
RLU	NULL
x	NULL
103	NULL
)	NULL
Vector	NULL
(	NULL
s	NULL
)	NULL
80	NULL
B	NULL
IL-2	NULL
P	NULL
CD28RE	NULL
mut	NULL
Luciferase	NULL
Activity	NULL
(	NULL
RLU	NULL
x	NULL
10°	NULL
)	NULL
65	NULL
yo*	NULL
ye®	NULL
®	NULL
B	NULL
r	NULL
*	NULL
a	NULL
965	NULL
]	NULL
)	NULL
&	NULL
@	NULL
5	NULL
‘	NULL
°	NULL
Vector	NULL
(	NULL
s	NULL
)	NULL
FIGURE	NULL
7	NULL
.	NULL

The	NULL
strong	NULL
frans-activation	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
induced	NULL
by	NULL
p65/c-Jun	NULL
is	NULL
abrogated	NULL
by	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
CD28RE-binding	NULL
site	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
cotransfected	NULL
with	NULL
p65	NULL
,	NULL
p65/c-Fos	NULL
,	NULL
p65/	NULL
c-Jun	NULL
,	NULL
or	NULL
p65/c-Fos/c-Jun	NULL
expression	NULL
plasmids	NULL
together	NULL
with	NULL
an	NULL
IL-2	NULL
promoter-luciferase	NULL
reporter	NULL
plasmid	NULL
containing	NULL
either	NULL
the	NULL
wild-type	NULL
promoter	NULL
of	NULL
the	NULL
IL-2	NULL
or	NULL
the	NULL
CD28RE	NULL
mutant	NULL
IL-2	NULL
promoter	NULL
.	NULL

The	NULL
transfected	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
subsequently	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SEE	NULL
and	NULL
the	NULL
CHO	NULL
(	NULL
untransfected	NULL
)	NULL
,	NULL
CHO-DR	NULL
,	NULL
CHO-DR/B7-1	NULL
,	NULL
CHO-DR/LFA-3	NULL
,	NULL
and	NULL
CHO-DR/B7-1/LFA-3	NULL
transfectants	NULL
.	NULL

The	NULL
native	NULL
CD28RE	NULL
sequence	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
-164	NULL
to	NULL
-154	NULL
,	NULL
AAAGAAATTCC	NULL
)	NULL
was	NULL
mutated	NULL
to	NULL
the	NULL
AAA-GACCTCGA	NULL
sequence	NULL
(	NULL
mutation	NULL
shown	NULL
in	NULL
boldface	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
is	NULL
expressed	NULL
as	NULL
RLU	NULL
minus	NULL
background	NULL
units	NULL
of	NULL
buffer	NULL
alone	NULL
(	NULL
A	NULL
)	NULL
or	NULL
as	NULL
fold	NULL
activation	NULL
over	NULL
the	NULL
value	NULL
obtained	NULL
from	NULL
unstimulated	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Both	NULL
sets	NULL
of	NULL
results	NULL
shown	NULL
are	NULL
mean	NULL
values	NULL
from	NULL
four	NULL
similar	NULL
experiments	NULL
.	NULL

Error	NULL
bars	NULL
indicate	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

intact	NULL
CD28RE	NULL
for	NULL
the	NULL
effect	NULL
of	NULL
c-Jun/p65	NULL
complex	NULL
in	NULL
the	NULL
up-reg-ulation	NULL
of	NULL
IL-2	NULL
promoter	NULL
activity	NULL
.	NULL

Our	NULL
present	NULL
data	NULL
support	NULL
a	NULL
role	NULL
for	NULL
the	NULL
CD28RE	NULL
in	NULL
integrating	NULL
AP-1-	NULL
and	NULL
Rel-mediated	NULL
transcriptional	NULL
events	NULL
which	NULL
seems	NULL
to	NULL
be	NULL
crucial	NULL
in	NULL
the	NULL
transition	NULL
from	NULL
low	NULL
(	NULL
autocrine	NULL
)	NULL
to	NULL
strong	NULL
IL-2	NULL
(	NULL
paracrine	NULL
)	NULL
transcription	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
the	NULL
CD28RE	NULL
may	NULL
work	NULL
in	NULL
conjunction	NULL
with	NULL
the	NULL
IL-2	NULL
promoter-proximal	NULL
AP-1	NULL
site	NULL
(	NULL
35	NULL
,	NULL
50	NULL
,	NULL
51	NULL
)	NULL
.	NULL

Our	NULL
analysis	NULL
using	NULL
CD28RE/AP-1	NULL
mutant	NULL
constructs	NULL
demonstrates	NULL
that	NULL
both	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
optimal	NULL
transcription	NULL
and	NULL
that	NULL
the	NULL
AP-1-prox-imal	NULL
sequence	NULL
cooperates	NULL
with	NULL
the	NULL
NF-KB	NULL
like	NULL
CD28RE	NULL
to	NULL
increase	NULL
the	NULL
IL-2	NULL
transcriptional	NULL
activity	NULL
in	NULL
B7-1-costimulated	NULL
cells	NULL
.	NULL

How	NULL
do	NULL
the	NULL
p65	NULL
and	NULL
c-Jun	NULL
proteins	NULL
cooperate	NULL
?	NULL

One	NULL
possibility	NULL
is	NULL
that	NULL
c-Jun	NULL
itself	NULL
or	NULL
in	NULL
conjunction	NULL
with	NULL
a	NULL
cofactor	NULL
protein	NULL
binds	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
flanking	NULL
the	NULL
CD28RE	NULL
and	NULL
stabilizes	NULL
the	NULL
binding	NULL
of	NULL
p65	NULL
.	NULL

A	NULL
role	NULL
for	NULL
AP-1	NULL
proteins	NULL
in	NULL
stabilizing	NULL
Rel-like	NULL
proteins	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
AP-1	NULL
participation	NULL
in	NULL
the	NULL
NE-AT	NULL
complex	NULL
confers	NULL
increased	NULL
DNA	NULL
binding	NULL
stability	NULL
of	NULL
NF-ATp	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
physical	NULL
interaction	NULL
between	NULL
members	NULL
of	NULL
the	NULL
bZip	NULL
protein	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
which	NULL
includes	NULL
AP-1	NULL
,	NULL
CREB	NULL
,	NULL
ATF	NULL
,	NULL
and	NULL
SRF	NULL
,	NULL
and	NULL
Rel	NULL
family	NULL
proteins	NULL
has	NULL
been	NULL
reported	NULL
in	NULL
several	NULL
other	NULL
promoters	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Gel	NULL
shift	NULL
experiments	NULL
5379	NULL
.	NULL

CHO-DR/LEFA-3	NULL
C-	NULL
]	NULL
CHO-DR/B7-1	NULL
__	NULL
R	NULL
CHO-DR/B7-1/LFA-3	NULL
30	NULL
A	NULL
IL-2	NULL
promoter	NULL
wild	NULL
type	NULL
f	NULL
S	NULL
251	NULL
E	NULL
19	NULL
H	NULL
3	NULL
20	NULL
ia	NULL
8	NULL
€	NULL
151	NULL
<	NULL
2	NULL
§	NULL
104	NULL
€	NULL
3	NULL
H0	NULL
55	NULL
I	NULL
o	NULL
1	NULL
ml	NULL
22	NULL
%	NULL
IL-2	NULL
wt	NULL
IL-2	NULL
+	NULL
c-Jun	NULL
IL-2	NULL
+	NULL
p65	NULL
IL-2+c-Jun/p6é5	NULL
Vector	NULL
(	NULL
s	NULL
)	NULL
40	NULL
B	NULL
IL-2	NULL
promoter	NULL
NF-	NULL
xB	NULL
mutant	NULL
30	NULL
20	NULL
10	NULL
7	NULL
Luciferase	NULL
Actiivty	NULL
(	NULL
RLUx10	NULL
*	NULL
)	NULL
IL-2	NULL
mt	NULL
IL-2	NULL
mt+	NULL
c-Jun	NULL
IL-2	NULL
mt+	NULL
p65	NULL
IL-2	NULL
mt+	NULL
c-Jun/p65	NULL
Vector	NULL
(	NULL
s	NULL
)	NULL
FIGURE	NULL
8.	NULL
p65/c-Jun	NULL
strongly	NULL
induced	NULL
a	NULL
NF-	NULL
«	NULL
B-mutated	NULL
IL-2	NULL
promoter	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
cotransfected	NULL
with	NULL
c-Jun	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
the	NULL
combination	NULL
of	NULL
p65	NULL
and	NULL
c-Jun	NULL
expression	NULL
plasmids	NULL
together	NULL
either	NULL
with	NULL
an	NULL
IL-2	NULL
promoter-luciferase	NULL
reporter	NULL
plasmid	NULL
either	NULL
containing	NULL
the	NULL
wild-type	NULL
promoter	NULL
of	NULL
the	NULL
IL-2	NULL
or	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
mutant	NULL
IL-2	NULL
promoter	NULL
.	NULL

The	NULL
transfected	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
subsequently	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SEE	NULL
and	NULL
the	NULL
CHO	NULL
(	NULL
untransfected	NULL
)	NULL
,	NULL
CHO-DR	NULL
,	NULL
CHO-DR/B7-1	NULL
,	NULL
CHO-DR/LFA-3	NULL
,	NULL
and	NULL
CHO-DR/B7-1/LFA-3	NULL
transfectants	NULL
.	NULL

The	NULL
native	NULL
NF-	NULL
«	NULL
B	NULL
sequence	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
AAAGAGGGATTTCACCT	NULL
was	NULL
mutated	NULL
to	NULL
the	NULL
sequence	NULL
AAAGAGGCTTTTCACCT	NULL
(	NULL
mutation	NULL
shown	NULL
in	NULL
boldface	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
is	NULL
expressed	NULL
as	NULL
RLU	NULL
minus	NULL
background	NULL
units	NULL
of	NULL
buffer	NULL
.	NULL

Both	NULL
sets	NULL
of	NULL
results	NULL
shown	NULL
are	NULL
mean	NULL
values	NULL
from	NULL
two	NULL
similar	NULL
experiments	NULL
.	NULL

have	NULL
indicated	NULL
that	NULL
CD28RE	NULL
has	NULL
a	NULL
low	NULL
affinity	NULL
for	NULL
p65	NULL
(	NULL
16	NULL
)	NULL
but	NULL
displays	NULL
a	NULL
more	NULL
prominent	NULL
binding	NULL
to	NULL
c-Rel	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
further	NULL
suggest	NULL
that	NULL
the	NULL
different	NULL
members	NULL
of	NULL
the	NULL
Fos/Jun	NULL
and	NULL
Rel	NULL
families	NULL
may	NULL
affect	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
a	NULL
distinct	NULL
manner	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Whereas	NULL
coexpression	NULL
of	NULL
c-Rel	NULL
and	NULL
c-jun	NULL
only	NULL
moderately	NULL
enhanced	NULL
the	NULL
luciferase	NULL
activity	NULL
in	NULL
LFA-3	NULL
costimulated	NULL
cells	NULL
,	NULL
coexpression	NULL
of	NULL
p65	NULL
and	NULL
c-jun	NULL
superinduced	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
IL-2	NULL
promoter	NULL
.	NULL

The	NULL
p50	NULL
subunit	NULL
was	NULL
unable	NULL
to	NULL
increase	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
or	NULL
CD28REs	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
p50	NULL
subunit	NULL
contains	NULL
a	NULL
weak	NULL
frans-activation	NULL
domain	NULL
or	NULL
that	NULL
it	NULL
may	NULL
bind	NULL
to	NULL
suppressive	NULL
factors	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
p50	NULL
,	NULL
c-Rel	NULL
and	NULL
p65	NULL
contain	NULL
strong	NULL
frans-activating	NULL
domains	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

The	NULL
p65	NULL
frans-activating	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
been	NULL
extensively	NULL
characterized	NULL
(	NULL
17	NULL
,	NULL
54	NULL
)	NULL
,	NULL
but	NULL
little	NULL
is	NULL
known	NULL
about	NULL
its	NULL
interaction	NULL
with	NULL
other	NULL
nuclear	NULL
factors	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
high	NULL
mobility	NULL
group	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
proteins	NULL
to	NULL
the	NULL
CD28RE	NULL
within	NULL
the	NULL
IL-2	NULL
strongly	NULL
potentiated	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
c-Rel	NULL
(	NULL
55	NULL
)	NULL
,	NULL
while	NULL
the	NULL
binding	NULL
of	NULL
Rel-A	NULL
was	NULL
not	NULL
increased	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
involvement	NULL
of	NULL
cofactors	NULL
can	NULL
modulate	NULL
the	NULL
activity	NULL
of	NULL
various	NULL
Rel	NULL
proteins	NULL
in	NULL
a	NULL
distinct	NULL
manner	NULL
.	NULL

It	NULL
remains	NULL
to	NULL
be	NULL
delineated	NULL
whether	NULL
high	NULL
mobility	NULL
group-like	NULL
proteins	NULL
that	NULL
interact	NULL
preferentially	NULL
with	NULL
p65	NULL
are	NULL
present	NULL
in	NULL
c-Jun/p65-transfected	NULL
Jurkat	NULL
cells	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
5380	NULL
p65	NULL
AND	NULL
c-Jun	NULL
OVEREXPRESSION	NULL
SUPERINDUCE	NULL
IL-2	NULL
PROMOTER	NULL
ACTIVITY	NULL
It	NULL
is	NULL
interesting	NULL
that	NULL
no	NULL
increase	NULL
in	NULL
IL-2	NULL
promoter	NULL
or	NULL
CD28RE/	NULL
AP-1	NULL
activity	NULL
can	NULL
be	NULL
detected	NULL
in	NULL
c-Rel-transfected	NULL
Jurkat	NULL
T	NULL
cells	NULL
because	NULL
of	NULL
a	NULL
large	NULL
amount	NULL
of	NULL
evidence	NULL
that	NULL
this	NULL
protein	NULL
is	NULL
important	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
.	NULL

Several	NULL
laboratories	NULL
have	NULL
now	NULL
reported	NULL
c-rel-specific	NULL
binding	NULL
to	NULL
the	NULL
CD28RE	NULL
(	NULL
16	NULL
,	NULL
35	NULL
,	NULL
51	NULL
,	NULL
55	NULL
)	NULL
and	NULL
c-Rel	NULL
,	NULL
but	NULL
not	NULL
p65	NULL
,	NULL
can	NULL
be	NULL
found	NULL
in	NULL
a	NULL
CD28RE/AP-1	NULL
specific	NULL
complex	NULL
also	NULL
containing	NULL
c-Fos/c-Jun	NULL
(	NULL
35	NULL
)	NULL
.	NULL

In	NULL
conjunction	NULL
with	NULL
the	NULL
decrease	NULL
in	NULL
IL-2	NULL
production	NULL
observed	NULL
in	NULL
c-Rel-deficient	NULL
mice	NULL
,	NULL
these	NULL
data	NULL
strongly	NULL
suggest	NULL
that	NULL
c-Rel	NULL
is	NULL
important	NULL
to	NULL
IL-2	NULL
promoter	NULL
activity	NULL
in	NULL
vivo	NULL
.	NULL

However	NULL
,	NULL
recent	NULL
studies	NULL
have	NULL
also	NULL
suggested	NULL
that	NULL
c-Rel	NULL
levels	NULL
in	NULL
the	NULL
nucleus	NULL
are	NULL
high	NULL
under	NULL
conditions	NULL
where	NULL
IL-2	NULL
promoter	NULL
activity	NULL
is	NULL
low	NULL
(	NULL
35	NULL
)	NULL
,	NULL
strongly	NULL
suggesting	NULL
that	NULL
c-Rel	NULL
is	NULL
not	NULL
a	NULL
limiting	NULL
factor	NULL
in	NULL
IL-2	NULL
production	NULL
but	NULL
that	NULL
some	NULL
other	NULL
mechanisms	NULL
limit	NULL
the	NULL
activity	NULL
of	NULL
this	NULL
promoter	NULL
in	NULL
suboptimal	NULL
stimulation	NULL
conditions	NULL
.	NULL

This	NULL
could	NULL
explain	NULL
the	NULL
inability	NULL
of	NULL
c-Rel	NULL
to	NULL
efficiently	NULL
trans-activate	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
transfected	NULL
Jurkat	NULL
T	NULL
cells	NULL
despite	NULL
playing	NULL
a	NULL
role	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
relevance	NULL
of	NULL
the	NULL
interaction	NULL
between	NULL
members	NULL
of	NULL
the	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
family	NULL
and	NULL
AP-1	NULL
transcription	NULL
factors	NULL
families	NULL
for	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
has	NULL
been	NULL
demonstrated	NULL
in	NULL
a	NULL
previous	NULL
study	NULL
showing	NULL
that	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
act	NULL
synergistically	NULL
with	NULL
NF-KB	NULL
to	NULL
trans-activate	NULL
a	NULL
xB	NULL
enhancer	NULL
element	NULL
or	NULL
an	NULL
AP-1	NULL
site	NULL
(	NULL
53	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
we	NULL
found	NULL
that	NULL
the	NULL
synergistic	NULL
effect	NULL
on	NULL
the	NULL
NF-	NULL
«	NULL
B-like	NULL
CD28RE	NULL
was	NULL
restricted	NULL
to	NULL
c-Jun	NULL
and	NULL
p65	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
overexpression	NULL
of	NULL
c-Fos	NULL
suppressed	NULL
the	NULL
potent	NULL
frans-activation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
by	NULL
p65	NULL
.	NULL

Positive	NULL
and	NULL
negative	NULL
effects	NULL
of	NULL
c-fos	NULL
have	NULL
been	NULL
reported	NULL
previously	NULL
(	NULL
56-59	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
propose	NULL
that	NULL
the	NULL
c-fos	NULL
suppresses	NULL
the	NULL
strong	NULL
transcriptional	NULL
activity	NULL
of	NULL
p65	NULL
.	NULL

Whether	NULL
this	NULL
involves	NULL
a	NULL
direct	NULL
protein-protein	NULL
interaction	NULL
between	NULL
p65	NULL
and	NULL
c-Fos	NULL
that	NULL
decreases	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
p65	NULL
,	NULL
sequestering	NULL
of	NULL
c-Jun	NULL
from	NULL
p65	NULL
by	NULL
formation	NULL
of	NULL
c-Jun/c-Fos	NULL
heterodimers	NULL
or	NULL
other	NULL
indirect	NULL
effects	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
a	NULL
c-Rel/	NULL
c-Jun	NULL
combination	NULL
was	NULL
not	NULL
reduced	NULL
by	NULL
c-Fos	NULL
expression	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
negative	NULL
effect	NULL
of	NULL
c-Fos	NULL
is	NULL
selective	NULL
for	NULL
the	NULL
p65	NULL
Rel	NULL
family	NULL
protein	NULL
.	NULL

Thus	NULL
,	NULL
both	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
are	NULL
able	NULL
to	NULL
affect	NULL
p65	NULL
activity	NULL
causing	NULL
a	NULL
dynamic	NULL
modulation	NULL
of	NULL
p65-mediated	NULL
transcription	NULL
of	NULL
the	NULL
CD28RE	NULL
.	NULL

T	NULL
cells	NULL
transfected	NULL
with	NULL
c-Jun/c-Fos	NULL
expressed	NULL
high	NULL
levels	NULL
of	NULL
an	NULL
AP-1	NULL
reporter	NULL
gene	NULL
activity	NULL
when	NULL
stimulated	NULL
with	NULL
DR/superantigen	NULL
but	NULL
failed	NULL
to	NULL
respond	NULL
to	NULL
CHO	NULL
+	NULL
SEE	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
signal	NULL
1	NULL
is	NULL
required	NULL
and	NULL
sufficient	NULL
for	NULL
posttran-scriptional	NULL
activation	NULL
of	NULL
c-Jun/c-Fos	NULL
proteins	NULL
when	NULL
these	NULL
are	NULL
expressed	NULL
in	NULL
high	NULL
levels	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
failure	NULL
of	NULL
signal	NULL
1	NULL
to	NULL
drive	NULL
the	NULL
AP-1	NULL
reporter	NULL
in	NULL
untransfected	NULL
cells	NULL
may	NULL
relate	NULL
to	NULL
the	NULL
low	NULL
expression	NULL
of	NULL
these	NULL
gene	NULL
products	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
B7-1	NULL
costimulation	NULL
superinduced	NULL
AP-1	NULL
activity	NULL
in	NULL
c-Jun/c-Fos-overexpressing	NULL
cells	NULL
may	NULL
reflect	NULL
that	NULL
CD28/B7-1	NULL
interaction	NULL
augment	NULL
the	NULL
JNK	NULL
protein	NULL
required	NULL
for	NULL
translational	NULL
activation	NULL
of	NULL
c-Jun	NULL
(	NULL
60	NULL
)	NULL
,	NULL
which	NULL
may	NULL
be	NULL
a	NULL
rate-limiting	NULL
step	NULL
in	NULL
c-Jun/	NULL
c-Fos-overexpressing	NULL
cells	NULL
.	NULL

Indeed	NULL
,	NULL
our	NULL
preliminary	NULL
data	NULL
demonstrate	NULL
profound	NULL
induction	NULL
of	NULL
JNK	NULL
activity	NULL
in	NULL
B7-1-	NULL
but	NULL
not	NULL
LFA-3-costimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

p65-transfected	NULL
Jurkat	NULL
T	NULL
cells	NULL
expressing	NULL
a	NULL
NF-KB	NULL
reporter	NULL
responded	NULL
only	NULL
moderately	NULL
to	NULL
signal	NULL
1	NULL
induction	NULL
.	NULL

B7-1	NULL
or	NULL
LFA-3	NULL
was	NULL
required	NULL
for	NULL
strong	NULL
transcription	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Whether	NULL
this	NULL
reflects	NULL
insufficient	NULL
degradation	NULL
of	NULL
IB	NULL
protein	NULL
is	NULL
presently	NULL
under	NULL
evaluation	NULL
.	NULL

LFA-3	NULL
and	NULL
B7-1	NULL
costimulation	NULL
of	NULL
p6S-expressing	NULL
Jurkat	NULL
cells	NULL
induced	NULL
similar	NULL
levels	NULL
of	NULL
NF-KB	NULL
,	NULL
while	NULL
the	NULL
response	NULL
of	NULL
a	NULL
CD28RE	NULL
reporter	NULL
was	NULL
severalfold	NULL
higher	NULL
in	NULL
B7-1	NULL
cells	NULL
.	NULL

Possibly	NULL
,	NULL
this	NULL
may	NULL
reflect	NULL
a	NULL
more	NULL
efficient	NULL
activation	NULL
of	NULL
endogenous	NULL
AP-1	NULL
protein	NULL
in	NULL
B7-1-costimulated	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
molecular	NULL
base	NULL
for	NULL
transition	NULL
from	NULL
a	NULL
LFA-3-dependent	NULL
autocrine	NULL
response	NULL
to	NULL
a	NULL
B7-1	NULL
paracrine	NULL
response	NULL
involves	NULL
induction	NULL
of	NULL
p65/c-Jun	NULL
and	NULL
targeting	NULL
of	NULL
the	NULL
CD28RE	NULL
within	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

Acknowledgments	NULL
We	NULL
gratefully	NULL
acknowledge	NULL
Dr.	NULL
C.	NULL
Verweij	NULL
(	NULL
Leiden	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
for	NULL
providing	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
Dr.	NULL
D.	NULL
Sansom	NULL
(	NULL
Bath	NULL
,	NULL
U.K.	NULL
)	NULL
for	NULL
providing	NULL
CHO	NULL
transfectants	NULL
,	NULL
Dr.	NULL
T.-H.	NULL
Tan	NULL
(	NULL
Houston	NULL
,	NULL
TX	NULL
)	NULL
for	NULL
providing	NULL
the	NULL
expression	NULL
plasmids	NULL
c-Rel	NULL
and	NULL
p65	NULL
,	NULL
and	NULL
Dr.	NULL
E.	NULL
Hatada	NULL
(	NULL
Berlin	NULL
,	NULL
Germany	NULL
)	NULL
for	NULL
providing	NULL
the	NULL
the	NULL
p50	NULL
expression	NULL
plasmid	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Samelson	NULL
,	NULL
L.	NULL
E.	NULL
1989	NULL
.	NULL

Lymphocyte	NULL
activation	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

2:210	NULL
.	NULL

2	NULL
.	NULL

Janeway	NULL
,	NULL
C.	NULL
1989	NULL
.	NULL

Immunogenicity	NULL
signals	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
...	NULL
and	NULL
0	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
10	NULL
:	NULL
283	NULL
.	NULL

3	NULL
.	NULL

Janeway	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
M.	NULL
Golstein	NULL
.	NULL

1993	NULL
.	NULL

Lymphocyte	NULL
activation	NULL
and	NULL
effector	NULL
func-tions	NULL
:	NULL
the	NULL
role	NULL
of	NULL
cell	NULL
surface	NULL
molecules	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

5:313	NULL
.	NULL

4	NULL
.	NULL

Jenkins	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
and	NULL
J.	NULL
G.	NULL
Johnson	NULL
.	NULL

1993	NULL
.	NULL

Molecules	NULL
involved	NULL
in	NULL
T-cell	NULL
costimulation	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

5:361	NULL
.	NULL

5	NULL
.	NULL

Dustin	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Sanders	NULL
,	NULL
S.	NULL
Shaw	NULL
,	NULL
and	NULL
T.	NULL
Springer	NULL
.	NULL

1987	NULL
.	NULL

Purified	NULL
lymphocyte	NULL
function-associated	NULL
antigen	NULL
3	NULL
binds	NULL
to	NULL
CD2	NULL
and	NULL
mediates	NULL
T	NULL
lymphocyte	NULL
adhesion	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

165:677	NULL
.	NULL

6	NULL
.	NULL

Turcovski-Corrales	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
R.	NULL
G.	NULL
Fenton	NULL
,	NULL
G.	NULL
Peltz	NULL
,	NULL
and	NULL
D.	NULL
D.	NULL
Taub	NULL
.	NULL

1995	NULL
.	NULL

CD28	NULL
:	NULL
B7	NULL
interaction	NULL
promote	NULL
T	NULL
cell	NULL
adhesion	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25:3087	NULL
.	NULL

7	NULL
.	NULL

Yiling	NULL
,	NULL
L.	NULL
,	NULL
A.	NULL
Granelli-Piperno	NULL
,	NULL
J.	NULL
M.	NULL
Bjorndahl	NULL
,	NULL
C.	NULL
A.	NULL
Phillips	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Trevillyan	NULL
.	NULL

1992	NULL
.	NULL

CD28-induced	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:24	NULL
.	NULL

8	NULL
.	NULL

June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
A.	NULL
Jeffrey	NULL
,	NULL
A.	NULL
Ledbetter	NULL
,	NULL
P.	NULL
S.	NULL
Linsley	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1990	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
CD28	NULL
receptor	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
11:211	NULL
.	NULL

9	NULL
.	NULL

Allison	NULL
,	NULL
J.	NULL
P.	NULL
1994	NULL
.	NULL

CD28/B7	NULL
interaction	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

6:414	NULL
.	NULL

10	NULL
.	NULL

Koyasu	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Lawton	NULL
,	NULL
D.	NULL
Novick	NULL
,	NULL
M.	NULL
A.	NULL
Recny	NULL
,	NULL
F.	NULL
Siliciano	NULL
,	NULL
B.	NULL
P.	NULL
Wallner	NULL
,	NULL
and	NULL
E.	NULL
L.	NULL
Reinherz	NULL
.	NULL

1990	NULL
.	NULL

Role	NULL
of	NULL
interaction	NULL
of	NULL
CD2	NULL
molecules	NULL
with	NULL
lymphocyte	NULL
function-associated	NULL
antigen	NULL
3	NULL
in	NULL
T-cell	NULL
recognition	NULL
of	NULL
nominal	NULL
antigen	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:2603	NULL
.	NULL

11	NULL
.	NULL

Bierer	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
S.	NULL
Herrmann	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Burakoff	NULL
.	NULL

1988	NULL
.	NULL

Interaction	NULL
of	NULL
CD2	NULL
with	NULL
its	NULL
ligand	NULL
,	NULL
LFA-3	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
proliferation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

140:3358	NULL
.	NULL

12	NULL
.	NULL

Parra	NULL
,	NULL
E.	NULL
,	NULL
A.	NULL
Gjorloff-Wingren	NULL
,	NULL
G.	NULL
Hedlund	NULL
,	NULL
M.	NULL
Bjorklund	NULL
,	NULL
H.	NULL
O.	NULL
Sjégren	NULL
,	NULL
T.	NULL
Kalland	NULL
,	NULL
D.	NULL
Sansom	NULL
,	NULL
and	NULL
M.	NULL
Dohisten	NULL
.	NULL

1994	NULL
.	NULL

Costimulation	NULL
of	NULL
human	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
with	NULL
B7	NULL
and	NULL
LFA-3	NULL
results	NULL
in	NULL
distinct	NULL
cell	NULL
activation	NULL
profiles	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:2479	NULL
.	NULL

13	NULL
.	NULL

Granelli-Piperno	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
P.	NULL
Nolan	NULL
.	NULL

1991	NULL
.	NULL

Nuclear	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
elements	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:2734	NULL
.	NULL

14	NULL
.	NULL

Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
J.	NULL
Shaw	NULL
,	NULL
M.	NULL
R.	NULL
Bush	NULL
,	NULL
R.	NULL
E.	NULL
Replogle	NULL
,	NULL
R.	NULL
Belagaje	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabiree	NULL
.	NULL

1988	NULL
.	NULL

Characterization	NULL
of	NULL
antigen	NULL
receptor	NULL
response	NULL
elements	NULL
within	NULL
the	NULL
interleukin-2	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:1715	NULL
.	NULL

15	NULL
.	NULL

Parra	NULL
,	NULL
E.	NULL
,	NULL
M.	NULL
Varga	NULL
,	NULL
M.	NULL
Sigvardsson	NULL
,	NULL
G.	NULL
Hedlund	NULL
,	NULL
T.	NULL
Kalland	NULL
,	NULL
T.	NULL
Leanderson	NULL
,	NULL
H.	NULL
O.	NULL
Sjogren	NULL
,	NULL
and	NULL
M.	NULL
Dohlsten	NULL
.	NULL

1995	NULL
.	NULL

Costimulation	NULL
of	NULL
human	NULL
CD4*	NULL
T	NULL
cells	NULL
with	NULL
LEA-3	NULL
and	NULL
B7	NULL
induce	NULL
distinct	NULL
effects	NULL
on	NULL
AP-1	NULL
and	NULL
NF-kB	NULL
transcription	NULL
factors	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:1132	NULL
.	NULL

16	NULL
.	NULL

Parra	NULL
,	NULL
E.	NULL
,	NULL
M.	NULL
Varga	NULL
,	NULL
G.	NULL
Hedlund	NULL
,	NULL
T.	NULL
Kalland	NULL
,	NULL
and	NULL
M.	NULL
Dohisten	NULL
.	NULL

1997	NULL
.	NULL

Costimulation	NULL
by	NULL
B7-1	NULL
and	NULL
LFA-3	NULL
target	NULL
distinct	NULL
nuclear	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
:	NULL
B7-1	NULL
negatively	NULL
regulates	NULL
LFA-3	NULL
induced	NULL
NF-AT	NULL
DNA	NULL
bind-ing	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:1314	NULL
.	NULL

17	NULL
.	NULL

Sicbenlist	NULL
,	NULL
U.	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
K.	NULL
Brown	NULL
.	NULL

1994	NULL
.	NULL

Structure	NULL
,	NULL
regulation	NULL
and	NULL
function	NULL
of	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

10:405	NULL
.	NULL

18	NULL
.	NULL

Serfling	NULL
,	NULL
E.	NULL
,	NULL
A.	NULL
Avots	NULL
,	NULL
and	NULL
M.	NULL
Neumann	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
architecture	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
:	NULL
a	NULL
reflection	NULL
of	NULL
T	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1263:181	NULL
.	NULL

19	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
T.	NULL
Henkel	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Anru	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:141	NULL
.	NULL

20	NULL
.	NULL

Verma	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
J.	NULL
K.	NULL
Stevenson	NULL
,	NULL
E.	NULL
M.	NULL
Schwarz	NULL
,	NULL
D.	NULL
Van	NULL
Antwerp	NULL
,	NULL
and	NULL
S.	NULL
Miyamoto	NULL
.	NULL

1995	NULL
.	NULL

Rel/NF-	NULL
«	NULL
B/I	NULL
«	NULL
B	NULL
family	NULL
:	NULL
intimate	NULL
tales	NULL
of	NULL
association	NULL
and	NULL
dissociation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:2723	NULL
.	NULL

21	NULL
.	NULL

Bull	NULL
,	NULL
P.	NULL
,	NULL
K.	NULL
L.	NULL
Morley	NULL
,	NULL
M.	NULL
F.	NULL
Hoekstra	NULL
,	NULL
T.	NULL
Hunter	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
mouse	NULL
c-rel	NULL
protein	NULL
has	NULL
an	NULL
N-terminal	NULL
regulatory	NULL
domain	NULL
and	NULL
a	NULL
C	NULL
terminal	NULL
transcriptional	NULL
transactivation	NULL
domain	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:5473	NULL
.	NULL

22	NULL
.	NULL

Lienhard	NULL
Schmitz	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
p65	NULL
subunit	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
strong	NULL
transcription	NULL
activating	NULL
potential	NULL
of	NULL
NF-kB	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:3805	NULL
.	NULL

23	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
J.	NULL
F.	NULL
Klement	NULL
,	NULL
T.	NULL
A.	NULL
Coleman	NULL
,	NULL
M.	NULL
Maher	NULL
,	NULL
C.-H.	NULL
Chen	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1992	NULL
.	NULL

I-Rel	NULL
:	NULL
a	NULL
novel	NULL
rel-related	NULL
protein	NULL
that	NULL
inhibits	NULL
NF-KB	NULL
transcriptional	NULL
activity	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:745	NULL
.	NULL

24	NULL
.	NULL

Tan	NULL
,	NULL
T.-H.	NULL
,	NULL
G.	NULL
P.	NULL
Huang	NULL
,	NULL
A.	NULL
Sica	NULL
,	NULL
P.	NULL
Ghosh	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
,	NULL
D.	NULL
Longo	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

1992	NULL
.	NULL

«	NULL
B	NULL
site-dependent	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
a-chain	NULL
gene	NULL
promoter	NULL
by	NULL
human	NULL
c-rel	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:4067	NULL
.	NULL

25	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
M.	NULL
Gifford	NULL
,	NULL
L.	NULL
R.	NULL
Riviere	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
p50	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
homology	NULL
to	NULL
rel	NULL
and	NULL
dorsal	NULL
.	NULL

Cell	NULL
62:1019	NULL
.	NULL

26	NULL
.	NULL

Grimm	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
inducible	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
:	NULL
structure-function	NULL
relationship	NULL
of	NULL
its	NULL
protein	NULL
subunits	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

290:297	NULL
.	NULL

27	NULL
.	NULL

Hay	NULL
,	NULL
R.	NULL
T.	NULL
1993	NULL
.	NULL

Control	NULL
of	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
activity	NULL
by	NULL
inhibitor	NULL
proteins	NULL
containing	NULL
ankyrin	NULL
repeats	NULL
.	NULL

Biochem	NULL
.	NULL

Soc	NULL
.	NULL

Trans	NULL
.	NULL

21:926	NULL
.	NULL

28	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
IKB	NULL
proteins	NULL
:	NULL
multifunctional	NULL
regulators	NULL
of	NULL
Rel/NF-	NULL
«	NULL
B	NULL
transcription	NULL
factors	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:1564	NULL
.	NULL

29	NULL
.	NULL

Traeckner	NULL
,	NULL
E.	NULL
,	NULL
H.	NULL
Pahl	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
K.	NULL
N.	NULL
Schmidt	NULL
,	NULL
S.	NULL
Wilk	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1995	NULL
.	NULL

Phosphorylation	NULL
of	NULL
human	NULL
IxB-	NULL
@	NULL
on	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
controls	NULL
IkB-	NULL
@	NULL
proteolysis	NULL
and	NULL
NF-KB	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
diverse	NULL
stimuli	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14	NULL
:	NULL
2876	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

Fraser	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Irving	NULL
,	NULL
G.	NULL
R.	NULL
Crabtree	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1991	NULL
.	NULL

Regulation	NULL
of	NULL
interleukin-2	NULL
gene	NULL
enhancer	NULL
activity	NULL
by	NULL
the	NULL
T	NULL
cell	NULL
accessory	NULL
molecule	NULL
CD28	NULL
.	NULL

Science	NULL
251:313	NULL
.	NULL

Ghos	NULL
,	NULL
P.	NULL
,	NULL
T.	NULL
Tan	NULL
,	NULL
N.	NULL
R.	NULL
Rice	NULL
,	NULL
A.	NULL
Sica	NULL
,	NULL
and	NULL
H.	NULL
A	NULL
Young	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
interleukin	NULL
2	NULL
CD28-responsive	NULL
complex	NULL
contains	NULL
at	NULL
least	NULL
three	NULL
members	NULL
of	NULL
the	NULL
xB	NULL
family	NULL
:	NULL
c-Rel	NULL
,	NULL
p50	NULL
and	NULL
p65	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:1696	NULL
.	NULL

Lai	NULL
,	NULL
J-H.	NULL
,	NULL
G.	NULL
Horvath	NULL
,	NULL
J.	NULL
Subleski	NULL
,	NULL
J.	NULL
Bruder	NULL
,	NULL
P.	NULL
Ghosh	NULL
,	NULL
and	NULL
T.-H.	NULL
Tan	NULL
.	NULL

1955	NULL
.	NULL

Rel	NULL
A	NULL
is	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
of	NULL
the	NULL
CD28	NULL
response	NULL
element	NULL
within	NULL
the	NULL
interleukin	NULL
2	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:4260	NULL
.	NULL

Verweij	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
M.	NULL
Geerts	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Aarden	NULL
.	NULL

1991	NULL
.	NULL

Activation	NULL
of	NULL
interleukin-2	NULL
gene	NULL
transcription	NULL
via	NULL
the	NULL
T-cell	NULL
surface	NULL
molecule	NULL
CD28	NULL
is	NULL
mediated	NULL
through	NULL
an	NULL
NF-B-like	NULL
response	NULL
element	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:14179	NULL
.	NULL

Civil	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Geerts	NULL
,	NULL
L.	NULL
A.	NULL
Aarden	NULL
,	NULL
and	NULL
C.	NULL
L.	NULL
Verweij	NULL
.	NULL

1992	NULL
.	NULL

Evidence	NULL
for	NULL
a	NULL
role	NULL
of	NULL
CD28RE	NULL
as	NULL
a	NULL
response	NULL
element	NULL
for	NULL
distinct	NULL
mitogenic	NULL
T	NULL
cell	NULL
activation	NULL
signal	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

22:3041	NULL
.	NULL

McGuire	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
M.	NULL
Tacobelli	NULL
.	NULL

1997	NULL
.	NULL

Involvement	NULL
of	NULL
Rel	NULL
,	NULL
Fos	NULL
and	NULL
Jun	NULL
proteins	NULL
in	NULL
binding	NULL
activity	NULL
to	NULL
the	NULL
interleukin	NULL
2	NULL
promoter	NULL
CD28RE/AP-1	NULL
sequence	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:1319	NULL
.	NULL

Fraser	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1992	NULL
.	NULL

Regulation	NULL
of	NULL
T-cell	NULL
lymphokine	NULL
gene	NULL
transcription	NULL
by	NULL
the	NULL
accessory	NULL
molecule	NULL
CD28	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:4357	NULL
.	NULL

Lee	NULL
,	NULL
W.	NULL
,	NULL
P.	NULL
Mitchell	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1987	NULL
.	NULL

Purified	NULL
transcriptional	NULL
factor	NULL
AP-1	NULL
interacts	NULL
with	NULL
TPA-inducible	NULL
enhancer	NULL
elements	NULL
.	NULL

Cell	NULL
49:741	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Imagawa	NULL
,	NULL
R.	NULL
Chiu	NULL
,	NULL
B.	NULL
Stein	NULL
,	NULL
R.	NULL
J.	NULL
Imbra	NULL
,	NULL
H.	NULL
J.	NULL
Rahmsdorf	NULL
,	NULL
C.	NULL
Jonat	NULL
,	NULL
P.	NULL
Herrlich	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1987	NULL
.	NULL

Phorbol	NULL
ester-inducible	NULL
genes	NULL
contain	NULL
a	NULL
common	NULL
cis	NULL
element	NULL
recognized	NULL
by	NULL
a	NULL
TPA-modulated	NULL
frans-acting	NULL
factor	NULL
.	NULL

Cell	NULL
49:729	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
role	NULL
of	NULL
jun	NULL
,	NULL
fos	NULL
and	NULL
the	NULL
AP-1	NULL
complex	NULL
in	NULL
cell-proliferation	NULL
and	NULL
transformation	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1072:129	NULL
.	NULL

Suzuki	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Okuno	NULL
,	NULL
T.	NULL
Yoshida	NULL
,	NULL
T.	NULL
Endo	NULL
,	NULL
H.	NULL
Nishina	NULL
,	NULL
and	NULL
H.	NULL
Tba	NULL
.	NULL

1991	NULL
.	NULL

Difference	NULL
in	NULL
transcriptional	NULL
regulatory	NULL
function	NULL
between	NULL
c-fos	NULL
and	NULL
fra-2	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19:5537	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
V.	NULL
E.	NULL
Valge-Archer	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
356:801	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
Z	NULL
.	NULL

Miner	NULL
,	NULL
T.	NULL
K.	NULL
Kerppola	NULL
,	NULL
J.	NULL
N.	NULL
Lambert	NULL
,	NULL
G.	NULL
L.	NULL
Verdine	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
T-cell	NULL
transcription	NULL
factor	NULL
NF-ATp	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
calcineurin	NULL
and	NULL
interacts	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
365:352	NULL
.	NULL

Castigli	NULL
,	NULL
E.	NULL
,	NULL
T.	NULL
A.	NULL
Chatila	NULL
,	NULL
and	NULL
R.	NULL
S.	NULL
Geha	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
protein	NULL
of	NULL
the	NULL
AP-1	NULL
family	NULL
is	NULL
a	NULL
component	NULL
of	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150:3284	NULL
.	NULL

De	NULL
Grazia	NULL
,	NULL
U.	NULL
,	NULL
M.	NULL
P.	NULL
Felli	NULL
,	NULL
A.	NULL
Vacca	NULL
,	NULL
A.	NULL
R.	NULL
Farina	NULL
,	NULL
M.	NULL
Maroder	NULL
,	NULL
L.	NULL
Cappa	NULL
Bianca	NULL
,	NULL
D.	NULL
Meco	NULL
,	NULL
M.	NULL
Farina	NULL
,	NULL
I.	NULL
Screpanti	NULL
,	NULL
L.	NULL
Frati	NULL
,	NULL
and	NULL
A.	NULL
Gulino	NULL
.	NULL

1994	NULL
.	NULL

Positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
the	NULL
composite	NULL
octamer	NULL
motif	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
enhancer	NULL
by	NULL
AP-1	NULL
,	NULL
Oct-2	NULL
,	NULL
and	NULL
retinoic	NULL
acid	NULL
receptor	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:1485	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
W.	NULL
Greene	NULL
,	NULL
P.	NULL
Angel	NULL
,	NULL
and	NULL
P.	NULL
Herrlich	NULL
.	NULL

1993	NULL
.	NULL

Cross-coupling	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
fos/jun	NULL
transcription	NULL
factors	NULL
produces	NULL
potentiated	NULL
biological	NULL
function	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:3879	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

5381	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
1994	NULL
.	NULL

NF-AT-AP-1	NULL
and	NULL
Rel-bZIP	NULL
:	NULL
hybrid	NULL
vigor	NULL
and	NULL
binding	NULL
under	NULL
the	NULL
influence	NULL
.	NULL

Cell	NULL
77:795	NULL
.	NULL

Gjorloff	NULL
,	NULL
A.	NULL
,	NULL
G.	NULL
Hedlund	NULL
,	NULL
T.	NULL
Kalland	NULL
,	NULL
D.	NULL
Sansom	NULL
,	NULL
H.	NULL
Fischer	NULL
,	NULL
J.	NULL
Trowsdale	NULL
,	NULL
H.	NULL
O.	NULL
Sjogren	NULL
,	NULL
and	NULL
M.	NULL
Dohlsten	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
LFA-3	NULL
adhesion	NULL
pathway	NULL
is	NULL
differently	NULL
utilized	NULL
by	NULL
superantigen-activated	NULL
human	NULL
CD4*	NULL
T	NULL
cell	NULL
subsets	NULL
.	NULL

Scand	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

36:243	NULL
.	NULL

Fischer	NULL
,	NULL
H.	NULL
,	NULL
G.	NULL
Hedlund	NULL
,	NULL
T.	NULL
Kalland	NULL
,	NULL
H.	NULL
O.	NULL
Sjégren	NULL
,	NULL
and	NULL
M.	NULL
Dohisten	NULL
.	NULL

1990	NULL
.	NULL

Independent	NULL
regulation	NULL
of	NULL
IFN-y	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
by	NULL
IL-1	NULL
in	NULL
human	NULL
T	NULL
helper	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

145:3767	NULL
.	NULL

Rincon	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1994	NULL
.	NULL

AP-1	NULL
transcriptional	NULL
activity	NULL
requires	NULL
both	NULL
T-cell	NULL
receptor-mediated	NULL
and	NULL
co-stimulatory	NULL
signals	NULL
in	NULL
primary	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:4370	NULL
.	NULL

Curtis	NULL
,	NULL
V.	NULL
E.	NULL
,	NULL
R.	NULL
Smilde	NULL
,	NULL
and	NULL
K.	NULL
Mcguire	NULL
.	NULL

1996	NULL
.	NULL

Requirements	NULL
for	NULL
IL-2	NULL
promoter	NULL
transactivation	NULL
by	NULL
the	NULL
tax	NULL
protein	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

16:3567	NULL
.	NULL

Shapiro	NULL
,	NULL
V.	NULL
S.	NULL
,	NULL
K.	NULL
E.	NULL
Truitt	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Imboden	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1997	NULL
.	NULL

CD28	NULL
mediates	NULL
transcriptional	NULL
upregulation	NULL
of	NULL
the	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
promoter	NULL
through	NULL
a	NULL
composite	NULL
element	NULL
containing	NULL
the	NULL
CD28RE	NULL
and	NULL
NF-IL-2B	NULL
AP-1	NULL
sites	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

10:4051	NULL
.	NULL

Hues	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Wakasugi	NULL
,	NULL
G.	NULL
Sterkers	NULL
,	NULL
J.	NULL
Gilmour	NULL
,	NULL
T.	NULL
Tursz	NULL
,	NULL
I.	NULL
Boumsell	NULL
,	NULL
and	NULL
A.	NULL
Bernard	NULL
.	NULL

1986	NULL
.	NULL

T	NULL
cell	NULL
activation	NULL
via	NULL
CD2	NULL
(	NULL
T	NULL
,	NULL
gp50	NULL
)	NULL
:	NULL
the	NULL
role	NULL
of	NULL
accessory	NULL
cells	NULL
in	NULL
activating	NULL
resting	NULL
cells	NULL
via	NULL
CD2	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

137:1420	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
P.	NULL
C.	NULL
Cogswell	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
.	NULL

Functional	NULL
and	NULL
physical	NULL
association	NULL
between	NULL
and	NULL
C-EBP	NULL
family	NULL
members	NULL
a	NULL
rel	NULL
domain-bZIP	NULL
interaction	NULL
.	NULL

1993	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3964	NULL
.	NULL

Grilli	NULL
,	NULL
M.	NULL
,	NULL
J.-S.	NULL
Jason	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Lenardo	NULL
.	NULL

1993	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
and	NULL
Rel	NULL
:	NULL
participants	NULL
in	NULL
a	NULL
multiform	NULL
transcriptional	NULL
regulatory	NULL
system	NULL
.	NULL

Int	NULL
.	NULL

Rev	NULL
.	NULL

Cytol	NULL
.	NULL

143:1	NULL
.	NULL

Himes	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
L.	NULL
S.	NULL
Coles	NULL
,	NULL
R.	NULL
Reeves	NULL
,	NULL
and	NULL
F.	NULL
Shannon	NULL
.	NULL

1996	NULL
.	NULL

High	NULL
mobility	NULL
group	NULL
protein	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
is	NULL
required	NULL
for	NULL
function	NULL
and	NULL
for	NULL
c-rel	NULL
binding	NULL
to	NULL
CD28	NULL
response	NULL
elements	NULL
within	NULL
the	NULL
GM-CSF	NULL
and	NULL
IL-2	NULL
promoters	NULL
.	NULL

Immunity	NULL
5:479	NULL
.	NULL

Sassone-Corsi	NULL
,	NULL
P.	NULL
,	NULL
J.	NULL
C.	NULL
Sisson	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1988	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
proto-oncogene	NULL
fos	NULL
.	NULL

Nature	NULL
334:314	NULL
.	NULL

Howcroft	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
J.	NULL
C.	NULL
Richardson	NULL
,	NULL
and	NULL
D.	NULL
S.	NULL
Singer	NULL
.	NULL

1993	NULL
.	NULL

MHC	NULL
class	NULL
I	NULL
gene	NULL
expression	NULL
is	NULL
negatively	NULL
regulated	NULL
by	NULL
the	NULL
proto-oncogene	NULL
,	NULL
c-jun	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12	NULL
:	NULL
3163	NULL
.	NULL

Trouche	NULL
,	NULL
D.	NULL
,	NULL
M.	NULL
Grigoriev	NULL
,	NULL
J.	NULL
L.	NULL
Lenormand	NULL
,	NULL
P.	NULL
Robin	NULL
,	NULL
S.	NULL
A.	NULL
Leibovitch	NULL
,	NULL
C.	NULL
P.	NULL
Sassone	NULL
,	NULL
and	NULL
B	NULL
.	NULL

A.	NULL
Harel	NULL
.	NULL

1993	NULL
.	NULL

Repression	NULL
of	NULL
c-fos	NULL
promoter	NULL
by	NULL
MyoD	NULL
on	NULL
muscle	NULL
cell	NULL
differentiation	NULL
.	NULL

Nature	NULL
363:79	NULL
.	NULL

Bengal	NULL
,	NULL
E.	NULL
,	NULL
L.	NULL
Ransone	NULL
,	NULL
R.	NULL
Scharman	NULL
,	NULL
V.	NULL
J.	NULL
Dwarki	NULL
,	NULL
S.	NULL
J.	NULL
Weintraub	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1992	NULL
.	NULL

Functional	NULL
antagonism	NULL
between	NULL
c-jun	NULL
and	NULL
MyoD	NULL
proteins	NULL
:	NULL
a	NULL
direct	NULL
physical	NULL
association	NULL
.	NULL

Cell	NULL
68:507	NULL
.	NULL

Su	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
Jacinto	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
T.	NULL
Kallunki	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
B.	NULL
Neriah	NULL
.	NULL

1994	NULL
.	NULL

JNK	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
integration	NULL
during	NULL
costimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
77	NULL
:	NULL
727	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL

